<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
<journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
<journal-id journal-id-type="pmc">F1000Research</journal-id>
<journal-title-group>
<journal-title>F1000Research</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-1402</issn>
<publisher>
<publisher-name>F1000 Research Limited</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32226609</article-id>
<article-id pub-id-type="pmc">7096214</article-id>
<article-id pub-id-type="doi">10.12688/f1000research.22037.1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Recent advances in mast cell activation and regulation</article-title>
<fn-group content-type="pub-status">
<fn>
<p>[version 1; peer review: 2 approved]</p>
</fn>
</fn-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hwan Soo</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5952-7849</contrib-id>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kawakami</surname>
<given-names>Yu</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kasakura</surname>
<given-names>Kazumi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kawakami</surname>
<given-names>Toshiaki</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding Acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0427-1217</contrib-id>
<xref ref-type="corresp" rid="c1">a</xref>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<aff id="a1">
<label>1</label>Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, California, 92037, USA</aff>
<aff id="a2">
<label>2</label>Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, South Korea</aff>
<aff id="a3">
<label>3</label>Department of Dermatlogy, University of California San Diego, School of Medicine, La Jolla, CA, 92093, USA</aff>
</contrib-group>
<author-notes>
<corresp id="c1">
<label>a</label>
<email xlink:href="mailto:toshi@lji.org">toshi@lji.org</email>
</corresp>
<fn fn-type="COI-statement">
<p>No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>9</volume>
<elocation-id>F1000 Faculty Rev-196</elocation-id>
<history>
<date date-type="accepted">
<day>6</day>
<month>3</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2020 Kim HS et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="f1000research-9-24303.pdf"></self-uri>
<abstract>
<p>Mast cells are innate immune cells that intersect with the adaptive immunity and play a crucial role in the initiation of allergic reactions and the host defense against certain parasites and venoms. When activated in an allergen- and immunoglobulin E (IgE)-dependent manner, these cells secrete a large variety of allergenic mediators that are pre-stored in secretory granules or
<italic>de novo</italic>–synthesized. Traditionally, studies have predominantly focused on understanding this mechanism of mast cell activation and regulation. Along this line of study, recent studies have shed light on what structural features are required for allergens and how IgE, particularly anaphylactic IgE, is produced. However, the last few years have seen a flurry of new studies on IgE-independent mast cell activation, particularly via Mrgprb2 (mouse) and MRGPRX2 (human). These studies have greatly advanced our understanding of how mast cells exert non-histaminergic itch, pain, and drug-induced pseudoallergy by interacting with sensory neurons. Recent studies have also characterized mast cell activation and regulation by interleukin-33 (IL-33) and other cytokines and by non-coding RNAs. These newly identified mechanisms for mast cell activation and regulation will further stimulate the allergy/immunology community to develop novel therapeutic strategies for treatment of allergic and non-allergic diseases.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Allergy</kwd>
<kwd>mast cells</kwd>
<kwd>allergen</kwd>
<kwd>IgE</kwd>
<kwd>FcεRI</kwd>
<kwd>MRGPRX2</kwd>
<kwd>IL-33</kwd>
<kwd>miRNA</kwd>
</kwd-group>
<funding-group>
<award-group id="fund-1">
<funding-source>US NIH</funding-source>
<award-id>R01AI146042</award-id>
<award-id>T32AI125179</award-id>
</award-group>
<award-group id="fund-2">
<funding-source>Kyowa Kirin Pharmaceutical Research</funding-source>
<award-id>N/A</award-id>
</award-group>
<funding-statement>Work in the authors’ laboratory is supported in part by National Institutes of Health (NIH) grant R01 AI146042 and Kyowa Kirin Pharmaceutical Research. YK is supported by NIH training grant T32 AI125179. </funding-statement>
<funding-statement>
<italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
</funding-statement>
</funding-group>
</article-meta>
<notes>
<sec sec-type="editor-note">
<title>Editorial Note on the Review Process</title>
<p>
<ext-link ext-link-type="uri" xlink:href="http://f1000research.com/browse/f1000-faculty-reviews">F1000 Faculty Reviews</ext-link> are commissioned from members of the prestigious
<ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/thefaculty">F1000 Faculty</ext-link> and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).</p>
<p>The referees who approved this article are: </p>
<list list-content="reviewer-list" list-type="simple">
<list-item>
<p>
<named-content content-type="reviewer-name">Cem Akin</named-content>, Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, MI, USA
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Jiro Kitaura</named-content>, Atopy Research Center, Juntendo University, Tokyo, Japan
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
</list>
</sec>
</notes>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Mast cells (MCs) play a crucial role in allergic reactions and the host defense against certain parasites, bacteria, and venoms. Morphologically, MCs are featured by a large number of secretory granules containing various bioactive molecules, including histamine, serotonin, proteoglycans, and proteases. Upon encounter with multivalent antigen (or allergen), antigen-specific immunoglobulin E (IgE)-bound high-affinity IgE receptors (FcεRI) on the surface of MCs are cross-linked or aggregated. Consequently, activation of the FcεRI signaling system is triggered, leading to the release of granular contents (degranulation) and
<italic>de novo</italic> synthesis and secretion of lipid mediators, cytokines, and chemokines. Activation of MCs entails immediate hypersensitivity and late-phase allergic inflammation. With regard to the IgE-mediated MC activation, recent years have seen a deeper understanding of IgE synthesis, structural features of allergens, FcεRI signaling mechanisms, and counter-mechanisms. Non-IgE-dependent MC activation mechanisms have been studied at a slow pace for many years. However, we have witnessed significant progress in this area more recently.</p>
<p>Murine MCs are classified as connective tissue MCs (CTMCs) and mucosal MCs (MMCs) on the basis of their tissue distribution. CTMCs and MMCs are also characterized by the heparin content of their granules: CTMCs contain a large amount of heparin in their granules, whereas MMCs have very little or no heparin. Human MC proteases include tryptases (mMCP-6 and -7 in mouse), chymases (mMCP-1, -2, and -4), an elastase (mMCP-5), and a carboxypeptidase-A3 (CPA3). Human MCs are categorized by expression of MC tryptase (MC
<sub>T</sub>) or MC chymase (MC
<sub>C</sub>) or both (MC
<sub>TC</sub>)
<sup><xref ref-type="bibr" rid="ref-1">1</xref></sup>. A recent transcriptional analysis demonstrated that the MC is one of the most transcriptionally variable cell types of the immune system
<sup><xref ref-type="bibr" rid="ref-2">2</xref></sup>. Murine MCs that were purified from different tissues shared an “MC-specific” transcriptional signature of at least 100 genes. Also, these MCs showed a tissue-specific regulation of their transcriptomes.</p>
<p>Substantial progress has recently been made in several areas of MC research, such as degranulation machinery, cancer, microbiota, and food allergy. Readers interested in these topics are referred to recent review articles
<sup><xref ref-type="bibr" rid="ref-3">3</xref>–
<xref ref-type="bibr" rid="ref-8">8</xref></sup>.</p>
</sec>
<sec>
<title>Allergen, immunoglobulin E, and FcεRI</title>
<p>A comprehensive understanding of the IgE-mediated MC activation requires a better knowledge of allergens, IgE synthesis and structure, and FcεRI structure and signaling pathways. Here, we highlight recent advances in this area, particularly allergens and IgE synthesis. We certainly know three-dimensional structures of many parts of IgE and FcεRI (composed of an IgE-binding α and receptor-stabilizing and signal-amplifying β and activation signal-triggering γ subunits)
<sup><xref ref-type="bibr" rid="ref-9">9</xref>,
<xref ref-type="bibr" rid="ref-10">10</xref></sup> and important principles in signaling, such as tyrosine phosphorylation of β and γ subunits at the immunoreceptor tyrosine-based activation motif (ITAM) by Src family kinases, the essential functions of Syk, Ca
<sup>2+</sup> flux, several adaptor molecules, mitogen-activated protein kinases (MAPKs), and several transcription factors
<sup><xref ref-type="bibr" rid="ref-11">11</xref>,
<xref ref-type="bibr" rid="ref-12">12</xref></sup>.</p>
<p>However, we feel obliged to note that our understanding of FcεRI signaling pathways is still in the early stages in light of an incomplete understanding of degranulation processes and a large number of genes regulated by MC activation.</p>
<p>One of the most important hypotheses on structural features of allergens stemmed from the requirement of cross-linking of cell surface IgE molecules by various allergens for MC activation and IgE synthesis. This line of thinking led Jensen-Jarolim
<italic>et al</italic>. to recognize that allergens display repetitive motifs, which they designate allergen-associated molecular patterns
<sup><xref ref-type="bibr" rid="ref-13">13</xref>,
<xref ref-type="bibr" rid="ref-14">14</xref></sup>. Indeed, many allergenic molecules occur as dimers or multimers. Some allergens—small proteins, in particular—have just a single immunodominant B-cell epitope and thus do not fulfill the requirement for cross-linking as a single molecular unit. Oligomerization provides the necessary means for efficient IgE cross-linking. Examples where only single dominant epitopes have been found are the allergens Der p 1 from house dust mite (HDM) and Bet v 1 from birch. Also, the occurrence of repetitive epitopes on single native allergen molecules has been shown on high-molecular-weight proteins of wheat and for HDMs and insects, cockroach Bla g 1, latex Hev b 5, and tropomyosin from shrimp.</p>
<p>IgE concentrations in serum are kept to the lowest level among immunoglobulin subtypes by several layers of regulation: in addition to the high rate of turnover, low efficiency of class-switch recombination to IgE, and lower surface expression of membrane IgE than that of IgG1 on germinal center (GC) B cells, IgE
<sup>+</sup> B cells are predisposed to swiftly exit GCs and differentiate into plasma cells (PCs) and IgE-producing GC B cells die by apoptosis
<sup><xref ref-type="bibr" rid="ref-15">15</xref>–
<xref ref-type="bibr" rid="ref-17">17</xref></sup>. Therefore, IgE
<sup>+</sup> memory B cells are scarce
<sup><xref ref-type="bibr" rid="ref-18">18</xref></sup>. Class switching of antigen-specific IgG1
<sup>+</sup> cells to become IgE
<sup>+</sup> cells, via the so-called sequential switching, was proposed as the mechanism involved in the production of affinity-matured IgE antibodies in memory responses
<sup><xref ref-type="bibr" rid="ref-19">19</xref></sup>. Using a culture system of induced GC B cells, Haniuda
<italic>et al</italic>. showed that the CD19-phosphatidylinositol 3-kinase (PI3K)-Akt-IRF4 axis is the essential pathway for PC differentiation and the BLNK-JNK-p38 axis serves an enhancing role in PC differentiation
<sup><xref ref-type="bibr" rid="ref-20">20</xref></sup>. They also showed that BLNK is essential for B-cell apoptosis and that CD19 is rather anti-apoptotic.</p>
<p>Recent studies have shown that T follicular helper (Tfh) cells are the primary T-cell subset responsible for IgE responses. Interleukin-4 (IL-4) is required to generate and sustain IgE production in mice
<sup><xref ref-type="bibr" rid="ref-21">21</xref></sup>. In response to allergens, T helper type 2 (Th2) and Tfh cells show unique cytokine responses, tissue localization, and phenotypes.
<italic>In vivo</italic>, Tfh cells assist the sustained production of IgE antibody. But conditional deficiency of Bcl6, the master regulator of Tfh, in CD4
<sup>+</sup> T cells
<sup><xref ref-type="bibr" rid="ref-22">22</xref></sup> results in a significant decrease in IgE antibody levels and Tfh cell numbers. However, eosinophilic inflammation and type 2 cytokine responses in the airways are not affected. Thus, Tfh-derived IL-4, but not Th2-derived IL-4, is necessary for IgE production
<sup><xref ref-type="bibr" rid="ref-23">23</xref></sup>. Gowthaman
<italic>et al</italic>. recently discovered a new Tfh subset in mice with T cell–specific Dock8 deficiency
<sup><xref ref-type="bibr" rid="ref-24">24</xref></sup>. These mice made allergen-specific anaphylactic IgE with the help of an IL-4– and IL-13–producing Tfh cell population called Tfh13 cells. Tfh13 cells have an unusual cytokine profile (IL-13
<sup>hi</sup>IL-4
<sup>hi</sup>IL-5
<sup>hi</sup>IL-21
<sup>lo</sup>) and co-express the transcription factors Bcl6 and GATA3. These cells are required for production of high- but not low-affinity IgE and subsequent allergen-induced anaphylaxis. Single-cell RNA sequencing analysis confirmed that Tfh13 cells are distinct from related Th2 or IL-4–expressing Tfh2 cells. Conditional ablation of Tfh13 cells or isolated loss of IL-13 in Tfh cells resulted in impaired anaphylactic IgE responses to allergens. Thus, blocking Tfh cells might represent a therapeutic means to ameliorate anaphylaxis.</p>
<p>We have known effects of monomeric IgE on FcεRI surface levels
<sup><xref ref-type="bibr" rid="ref-25">25</xref>,
<xref ref-type="bibr" rid="ref-26">26</xref></sup> and on survival of MCs
<sup><xref ref-type="bibr" rid="ref-27">27</xref>,
<xref ref-type="bibr" rid="ref-28">28</xref></sup> in the absence of allergen for a long time. A recent study showed that IL-3 but not monomeric IgE regulates FcεRI expression and cell survival in primary human basophils, in contrast to human and murine MCs
<sup><xref ref-type="bibr" rid="ref-29">29</xref></sup>.</p>
</sec>
<sec>
<title>Mast cell activation by interleukin-33</title>
<p>IL-33 belongs to the IL-1 family and is expressed by several cell types, including epithelial cells
<sup><xref ref-type="bibr" rid="ref-30">30</xref>–
<xref ref-type="bibr" rid="ref-33">33</xref></sup>. IL-33 binds to a specific receptor called T1/ST2 (ST2) that belongs to the Toll-like receptor/IL1R family. ST2 forms heterodimers with the IL-1 receptor accessory protein (IL-1RAcP), namely a transmembrane form (ST2 or ST2L) and a soluble form (sST2). ST2L isoform is expressed on MCs, basophils, Th2 cells, and natural killer cells and coordinates spatially and temporally with IL-33 signaling, which might trigger a key regulatory amplification loop involved in immune homeostasis. IL-33 is considered an alarmin as it is released after necrosis or tissue damage. However, apoptosis leads to the inactivation of IL-33 by cleavage of IL-33 by caspases. In contrast, MC serine proteases cleave the full-length IL-33 (IL-33
<sub>1–270</sub>) and liberate active forms: IL-33
<sub>95–270</sub>, IL-33
<sub>99–270</sub>, and IL-33
<sub>109–270</sub>. These cleaved forms have 10 times greater potency than the full-length protein
<sup><xref ref-type="bibr" rid="ref-34">34</xref></sup>. MC chymase also degrades IL-33 that leads to higher bioactivity
<sup><xref ref-type="bibr" rid="ref-35">35</xref></sup>. Downstream of ST2, the IL-33–mediated signaling pathway involves MyD88, IRAK1, IRAK4, and TRAF6 as well as activation of MAPKs (ERK1/2, p38, and JNK1/2) and nuclear factor-kappa B (NF-κB)
<sup><xref ref-type="bibr" rid="ref-36">36</xref>,
<xref ref-type="bibr" rid="ref-37">37</xref></sup>.</p>
<p>IL-33 can induce full activation of MCs, including degranulation
<sup><xref ref-type="bibr" rid="ref-38">38</xref></sup> and production of several cytokines and chemokines
<sup><xref ref-type="bibr" rid="ref-39">39</xref></sup>, and elicits systemic MC-dependent anaphylaxis
<sup><xref ref-type="bibr" rid="ref-38">38</xref></sup>. Several studies have shown that IL-33 plays a significant role in severe asthma
<sup><xref ref-type="bibr" rid="ref-40">40</xref></sup> and refractory nasal polyposis
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>. Earlier studies have been summarized in excellent reviews
<sup><xref ref-type="bibr" rid="ref-42">42</xref>–
<xref ref-type="bibr" rid="ref-44">44</xref></sup>. Here, we touch on newer reports that showed a possible role of IL-33 in various allergic conditions: IL-33–mediated airway constriction was exacerbated through increased secretion of serotonin from MCs
<sup><xref ref-type="bibr" rid="ref-45">45</xref></sup>.
<italic>Staphylococcus aureus</italic>–derived serine protease-like protein (Spl) D is a potent allergen and induces a Th2-biased inflammatory response in the airways in an IL-33–dependent manner
<sup><xref ref-type="bibr" rid="ref-46">46</xref></sup>. Aspirin-exacerbated respiratory disease (AERD) is a severe eosinophilic disorder of the airways and is characterized by overproduction of cysteinyl leukotrienes, activation of airway MCs, and bronchoconstriction in response to non-selective cyclooxygenase inhibitors that deplete prostaglandin E
<sub>2</sub> (PGE
<sub>2</sub>) (
<xref ref-type="fig" rid="f1">Figure 1</xref>). A study using clinical samples and mice deficient in PGE
<sub>2</sub> synthase (a model of AERD) found up-regulation of IL-33 in airway epithelium
<sup><xref ref-type="bibr" rid="ref-47">47</xref></sup>. Deletion of leukotriene C4 synthase in the AERD model mice eliminates the increased IL-33, lung eosinophilia, and aspirin-induced MC activation and bronchoconstriction. MCs have been shown to play a crucial role in a model of skin inflammation by IL-33–mediated recruitment of leukocytes and resulting inflammation in an MK2/3 (MAPK-activated protein kinases 2 and 3)-dependent manner
<sup><xref ref-type="bibr" rid="ref-48">48</xref></sup>. In a murine model of food allergy, IL-33 and MCs promote inflammation in the gastrointestinal tract through IL-4 production by IL-33–stimulated ILC2s, as IL-4 blocks the generation of allergen-specific regulatory T (Treg) cells
<sup><xref ref-type="bibr" rid="ref-49">49</xref>–
<xref ref-type="bibr" rid="ref-51">51</xref></sup>. However, on the positive side, IL-33 and MCs play a protective role in intestinal helminth infections by activating ILC2, leading to helminth expulsion
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>. MCs can ameliorate IL-33–mediated inflammatory effects under certain circumstances. Stimulation of MCs with IL-33 in the absence of IgE cross-linking can induce Treg cell expansion by producing IL-2 and reduce the inflammation in a papain-induced innate-type airway inflammation model
<sup><xref ref-type="bibr" rid="ref-53">53</xref></sup>.</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="anchor">
<label>Figure 1. </label>
<caption>
<title>Mechanisms underlying response to cyclooxygenase 1 (COX-1) inhibitors in patients with aspirin-exacerbated respiratory disease (AERD)</title>
<p>Patients with AERD show lower levels of COX-2 compared with the healthy population. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit COX-1 and lower the level of prostaglandin E
<sub>2</sub> (PGE
<sub>2</sub>). The loss of PGE
<sub>2</sub> inhibitory control leads to massive release of histamine and generation of cysteinyl leukotrienes by mast cells, an event that is unique to AERD. Red arrows represent abnormal baseline conditions in patients with AERD, and blue arrows indicate changes after COX-1 inhibition. The size of the arrows indicates the magnitude of change. 5-HPETE, 5-hydroperoxyeicosatetraenoic acid; 5-LO, 5-lipoxygenase; LT, leukotriene (A4, C4, D4, and E4); PG, prostaglandin (G2, H2, I2, and F2); TXA2, thromboxane A2.</p>
</caption>
<graphic xlink:href="f1000research-9-24303-g0000"></graphic>
</fig>
</sec>
<sec>
<title>Mast cell activation via Mrgprb2/MRGPRX2</title>
<p>Mas-related G protein–coupled receptor-X2 (MRGPRX2) has been the hottest receptor in MC research over the last few years
<sup><xref ref-type="bibr" rid="ref-54">54</xref></sup>. Mrgprb2 is the murine ortholog of MRGPRX2. Under homeostatic conditions, CTMCs in the skin and peritoneum of mice express Mrgprb2, whereas MMCs do not express Mrgprb2
<sup><xref ref-type="bibr" rid="ref-55">55</xref></sup>. Mrgprb2/MRGPRX2 recognizes a wide range of cationic molecules, including substance P (SP), basic secretagogues (for example, compound 48/80), numerous US Food and Drug Administration–approved drugs, and endogenous protein fragments
<sup><xref ref-type="bibr" rid="ref-55">55</xref>–
<xref ref-type="bibr" rid="ref-57">57</xref></sup>. Mrgprb2/MRGPRX2-mediated activation of MCs by these ligands results in their rapid degranulation of individual granules and MC-dependent local inflammation, whereas FcεRI-elicited secretion is delayed but progressive and is characterized by granule-to-granule fusions
<sup><xref ref-type="bibr" rid="ref-58">58</xref></sup>.</p>
<p>MRGPRX2 has been implicated in allergic and chronic inflammatory diseases. LL-37, the catheliciden peptide and MRGPRX2 agonist
<sup><xref ref-type="bibr" rid="ref-59">59</xref>,
<xref ref-type="bibr" rid="ref-60">60</xref></sup>, is up-regulated in rosacea
<sup><xref ref-type="bibr" rid="ref-61">61</xref></sup>, and MCs play a key role as the primary source of LL-37 in a murine model of rosacea
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>. The pathology in asthma
<sup><xref ref-type="bibr" rid="ref-63">63</xref></sup> and urticaria
<sup><xref ref-type="bibr" rid="ref-64">64</xref></sup> correlates with MC-specific expression of MRGPRX2. Mrgprb2 inactive mutant Mrgprb2
<sup>mut/mut</sup> mice
<sup><xref ref-type="bibr" rid="ref-55">55</xref></sup> show reduced itch in multiple models of allergic contact dermatitis (ACD), a pruritic inflammatory skin disorder. MC numbers and PAMP1-20 (MRGPRX2 agonist) concentrations are increased in human ACD skin
<sup><xref ref-type="bibr" rid="ref-65">65</xref></sup>, which is associated with pathogenic CD8 T-cell responses
<sup><xref ref-type="bibr" rid="ref-66">66</xref></sup>. MCs are found in close proximity to peripheral nerve endings
<sup><xref ref-type="bibr" rid="ref-67">67</xref>–
<xref ref-type="bibr" rid="ref-69">69</xref></sup>. Atopic dermatitis, another pruritic skin disease, has been studied by using a mouse model sensitized and challenged with HDMs in the presence of staphylococcal enterotoxin B
<sup><xref ref-type="bibr" rid="ref-70">70</xref></sup>. Using this model, a recent study shows that HDMs with cysteine protease activity directly activate peptidergic nociceptors on sensory neurons expressing the ion channel TRPV1 and
<italic>Tac1</italic> (gene encoding the precursor for SP)
<sup><xref ref-type="bibr" rid="ref-71">71</xref></sup>. HDM-activated nociceptors drive the development of allergic skin inflammation by SP/Mrgprb2-mediated activation of MCs
<sup><xref ref-type="bibr" rid="ref-71">71</xref></sup>. Another study indicates that activation of the natriuretic polypeptide b (Nppb)-expressing class of sensory neurons elicits scratching responses in mice
<sup><xref ref-type="bibr" rid="ref-72">72</xref></sup>. Interestingly, however, Nppb
<sup>+</sup> neurons express receptors for leukotrienes, serotonin and sphingosine-1-phosphate, and these receptors induce itch by the direct activation of Nppb
<sup>+</sup> neurons and neurotransmission through the canonical gastrin-releasing peptide-dependent spinal cord itch pathway
<sup><xref ref-type="bibr" rid="ref-72">72</xref></sup>. Mrgprb2/MRGPRX2 is also involved in inflammatory mechanical and thermal hyperalgesia
<sup><xref ref-type="bibr" rid="ref-73">73</xref></sup>. In this case, SP activates MCs via Mrgprb2/MRGPRX2 to release multiple pro-inflammatory cytokines and chemokines, which facilitate the migration of immune cells. It is noteworthy that SP-mediated activation of MCs does not involve its canonical receptor, neurokinin 1 receptor (NK-1R). However, activation of NK-1R by hemokinin-1 likely contributes to allergic airway inflammation in mice, whereas activation of the human MC line LAD-2 by hemokinin-1 requires MRGPRX2. MRGPRX2 expression is upregulated in lung MCs from patients with lethal asthma
<sup><xref ref-type="bibr" rid="ref-63">63</xref></sup>.</p>
<p>Studies of Mrgprb2/MRGPRX2-mediated MC activation have been extended to their new ligands, signal transduction, effects of other MC modulators, and so on. For example, compound 48/80, AG-30/5C (angiogenic defense peptide), and icatibant (bradykinin B2 receptor antagonist) all activate pertussis toxin-sensitive G proteins, but only compound 48/80 activates β-arrestin
<sup><xref ref-type="bibr" rid="ref-74">74</xref></sup>. The same study also found resveratrol (polyphenolic compound in peanuts, grapes, red wine, and some berries) as an inhibitor of MRGPRX2. As the FcεRI signaling is initiated by tyrosine phosphorylation with Src, Syk, and Tec family kinases while Mrgprb2 and MRGPRX2 are G protein–coupled receptors, FcεRI- and MRGPRX2-stimulated pathways are completely independent of each other
<sup><xref ref-type="bibr" rid="ref-75">75</xref></sup>. Stem cell factor (SCF) and IL-4, which are the two main MC differentiation and growth factors, negatively regulate MRGPRX2 expression in human skin MCs, whereas SCF promotes allergic stimulation via FcεRI
<sup><xref ref-type="bibr" rid="ref-76">76</xref></sup>. In contrast, pre-incubation (20 minutes) of human MCs with IL-33 or IL-6 or both does not affect their activation with SP, whereas such priming, particularly that with both IL-33 and IL-6, enhances IgE/allergen-mediated MC activation
<sup><xref ref-type="bibr" rid="ref-77">77</xref></sup>. Another study shows that chronic exposure (5 weeks) of human MCs to IL-33 reduces FcεRI expression and responsiveness to its aggregation
<sup><xref ref-type="bibr" rid="ref-78">78</xref></sup>. Short-term (30 minutes) pre-incubation with IL-33 enhances MRGPRX2-mediated degranulation by SP or compound 48/80 without changing MRGPRX2 expression, whereas chronic (5 weeks) pre-treatment with IL-33 reduces mRNA and protein expression of MRGPRX2 and its function
<sup><xref ref-type="bibr" rid="ref-79">79</xref></sup>. MCs are also required for cardiac fibrosis in multiple animal models. Interestingly, NK-1R expression in MCs is not required in cardiac fibrosis
<sup><xref ref-type="bibr" rid="ref-80">80</xref></sup>. It should be tested whether Mrgprb2 is involved in this process.</p>
</sec>
<sec>
<title>MicroRNA and mast cell biology</title>
<p>MicroRNA (miRNA), a small non-coding RNA molecule that is 19 to 25 nucleotides in length, functions in post-transcriptional regulation and RNA silencing of gene expression. miRNAs work by base pairing with complementary sequences inside of mRNA molecules. Because of the broad regulatory mechanisms, miRNAs regulate differentiation, proliferation, survival, apoptosis, stress response, and the effector function as well as the resolution of an immune response
<sup><xref ref-type="bibr" rid="ref-81">81</xref>,
<xref ref-type="bibr" rid="ref-82">82</xref></sup>.</p>
<p>Numerous studies have examined the role of miRNAs in MC biology (
<xref ref-type="table" rid="T1">Table 1</xref>)
<sup><xref ref-type="bibr" rid="ref-83">83</xref></sup>. Silencing of Dicer, a key enzyme of miRNA biogenesis, attenuates degranulation, indicating that miRNAs are involved in MC activation. Overexpression of miR-142-3p, which rescues Dicer expression, enhances FcεRI-mediated degranulation in MCs
<sup><xref ref-type="bibr" rid="ref-84">84</xref></sup>. IgE/antigen stimulation of bone marrow–derived MCs induces up- or down-regulation of several miRNAs, which affects mRNA expression of some key signaling molecules, including Lyn, Vav3, and Csf2
<sup><xref ref-type="bibr" rid="ref-85">85</xref>,
<xref ref-type="bibr" rid="ref-86">86</xref></sup>. miR-155 plays a critical role in FcεRI-mediated MC responses by modulating components of the PI3Kγ pathway, and miR-155–deficient mice show enhanced anaphylaxis
<sup><xref ref-type="bibr" rid="ref-87">87</xref></sup>. Down-regulation of miR-155 in MCs is also involved in suppression of IL-33–induced inflammation by lactic acid
<sup><xref ref-type="bibr" rid="ref-88">88</xref></sup> or of IL-33–induced IL-6 production in MCs
<sup><xref ref-type="bibr" rid="ref-89">89</xref></sup>. As a basis of IL-10–mediated MC regulation, IL-10–induced miR-155 expression enhances protease and cytokine production in MCs by suppressing SOCS1, a suppressor of cytokine signaling
<sup><xref ref-type="bibr" rid="ref-90">90</xref></sup>. A novel miRNA let7i inhibits MC degranulation by suppressing expression of
<italic>Exoc8</italic>, which is an exocytosis-related gene
<sup><xref ref-type="bibr" rid="ref-91">91</xref></sup>. MiR-126 accelerates IgE-mediated MC degranulation, which is associated with PI3K/Akt activation and increased Ca
<sup>2+</sup> influx
<sup><xref ref-type="bibr" rid="ref-92">92</xref></sup>. MiR-223 reduces IL-6 secretion in MCs by inhibiting the IGF1R/PI3K signaling pathway
<sup><xref ref-type="bibr" rid="ref-93">93</xref></sup>. Expression of miR-210 and miRNA-132/212 cluster is increased by IgE-mediated MC activation
<sup><xref ref-type="bibr" rid="ref-94">94</xref></sup>. MiR-21 inhibits MC degranulation by inhibiting the p38 pathway in a murine model of ACD
<sup><xref ref-type="bibr" rid="ref-95">95</xref></sup>. MiR-221-222 is up-regulated in MC stimulation and regulates the cell cycle by inhibiting p27
<sup>Kip1</sup> expression
<sup><xref ref-type="bibr" rid="ref-96">96</xref>,
<xref ref-type="bibr" rid="ref-97">97</xref></sup>. MiR-221-3p, which is markedly increased in asthmatics, up-regulates IL-4 secretion from MCs by targeting phosphatase and tensin homolog (PTEN) as well as activation of p38 and NF-κB
<sup><xref ref-type="bibr" rid="ref-98">98</xref></sup>. MiR-302e negatively regulates RelA/p65 expression in MCs and ameliorates allergic inflammation through inhibition of the NF-κB signaling pathway
<sup><xref ref-type="bibr" rid="ref-99">99</xref></sup>. MiR-143 and miR-146 reduce MC activation by targeting IL-13Rα1 and TRAF/IRAK, respectively, leading to a reduced allergic response
<sup><xref ref-type="bibr" rid="ref-100">100</xref>–
<xref ref-type="bibr" rid="ref-103">103</xref></sup>. miR-20a inhibits expression of tumor necrosis factor (TNF), IL-1β, and interferon gamma (IFN-γ) while promoting IL-10 in HMC-1 human MCs. miR-20a also targets histone deacetylase 4 (HDAC4), which contributes to the epigenetic regulation of IL-10 expression
<sup><xref ref-type="bibr" rid="ref-104">104</xref></sup>.</p>
<table-wrap id="T1" orientation="portrait" position="anchor">
<label>Table 1. </label>
<caption>
<title>MicroRNA (miRNA) functions in mast cell activation and proliferation.</title>
</caption>
<table content-type="article-table" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">miRNA</th>
<th align="left" colspan="1" rowspan="1" valign="top">Trigger</th>
<th align="left" colspan="1" rowspan="1" valign="top">miRNA effect on mast cells</th>
<th align="left" colspan="1" rowspan="1" valign="top">Target mRNA</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-142</td>
<td align="left" colspan="1" rowspan="1" valign="top">FcεRI</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase degranulation</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-81">81</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-155</td>
<td align="left" colspan="1" rowspan="1" valign="top">FcεRI
<break></break>IL-33
<break></break>IL-10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ca
<sup>2+</sup> influx with degranulation
<break></break>Increase cytokine production
<break></break>Increase cytokine production</td>
<td align="left" colspan="1" rowspan="1" valign="top">PI3K
<break></break>
<break></break>SOCS1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-84">84</xref>–
<xref ref-type="bibr" rid="ref-87">87</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Let-7i</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Decrease degranulation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Exoc8</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-88">88</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-126</td>
<td align="left" colspan="1" rowspan="1" valign="top">FcεRI</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increases degranulation</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-89">89</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-223</td>
<td align="left" colspan="1" rowspan="1" valign="top">FcεRI</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decrease granulation and interluekin-6 (IL-6) release</td>
<td align="left" colspan="1" rowspan="1" valign="top">IGF1R</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-90">90</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-210</td>
<td align="left" colspan="1" rowspan="1" valign="top">FcεRI</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-91">91</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-132/212</td>
<td align="left" colspan="1" rowspan="1" valign="top">FcεRI</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HB-EGF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-91">91</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-21</td>
<td align="left" colspan="1" rowspan="1" valign="top">Allergic inflammation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decrease degranulation and IL-12 production</td>
<td align="left" colspan="1" rowspan="1" valign="top">IL-12p35
<break></break>P38</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-92">92</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-221/222</td>
<td align="left" colspan="1" rowspan="1" valign="top">FcεRI</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulate proliferation and cell cycle
<break></break>Increases degranulation and cytokine production; reduces migration</td>
<td align="left" colspan="1" rowspan="1" valign="top">p27
<sup>Kip1</sup>, PTEN</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-93">93</xref>–
<xref ref-type="bibr" rid="ref-95">95</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-302e</td>
<td align="left" colspan="1" rowspan="1" valign="top">FcεRI
<break></break>PMA/IONO</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decrease cytokine secretion</td>
<td align="left" colspan="1" rowspan="1" valign="top">RelA</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-96">96</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-146</td>
<td align="left" colspan="1" rowspan="1" valign="top">FcεRI</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduces activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRAF6, IRAK1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-97">97</xref>–
<xref ref-type="bibr" rid="ref-99">99</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-143</td>
<td align="left" colspan="1" rowspan="1" valign="top">Allergic inflammation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down-regulate allergic response</td>
<td align="left" colspan="1" rowspan="1" valign="top">IL-13Rα1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-100">100</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-20a</td>
<td align="left" colspan="1" rowspan="1" valign="top">PMA/IONO</td>
<td align="left" colspan="1" rowspan="1" valign="top">Activate mast cells (MCs)
<break></break>Inhibit production of pro-inflammatory cytokines</td>
<td align="left" colspan="1" rowspan="1" valign="top">HDAC4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-101">101</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-4443</td>
<td align="left" colspan="1" rowspan="1" valign="top">T cell–derived microvesicle</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase ERK phosphorylation and IL-8 release</td>
<td align="left" colspan="1" rowspan="1" valign="top">PTPRJ</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-102">102</xref>–
<xref ref-type="bibr" rid="ref-108">108</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-490</td>
<td align="left" colspan="1" rowspan="1" valign="top">HCV-E2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Inhibits tumor metastasis</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-109">109</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-9</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase invasion of neoplastic MCs</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-110">110</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">miR-122</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tumor response</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decrease activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOCS1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-111">111</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Shefler
<italic>et al</italic>. showed that MCs are activated by interaction with activated T cells or their microvesicles (mvT*s)
<sup><xref ref-type="bibr" rid="ref-105">105</xref>,
<xref ref-type="bibr" rid="ref-106">106</xref></sup>. The physical contact of MCs with activated T cells or with mvT*s induces Ras activation and ERK phosphorylation, leading to degranulation and release of several cytokines in MCs
<sup><xref ref-type="bibr" rid="ref-106">106</xref>–
<xref ref-type="bibr" rid="ref-110">110</xref></sup>. The same group later found that miR-4443 in mvT*s targets the expression of protein tyrosine phosphatase receptor type J (PTPRJ), a known ERK inhibitor
<sup><xref ref-type="bibr" rid="ref-111">111</xref></sup>. Several miRNAs that play a role in cancer have recently been discovered: miR-9 increases the invasion of neoplastic MCs
<sup><xref ref-type="bibr" rid="ref-112">112</xref></sup>. miR-122 targets SOCS1 mRNA and regulates cellular interactions involving cancer cells, MCs, and macrophages during allergic inflammation
<sup><xref ref-type="bibr" rid="ref-113">113</xref></sup>. Exosomal miRNAs have emerged as mediators of the interaction between MCs and tumor cells. MCs can inhibit hepatocellular carcinoma cell metastasis by inhibiting the ERK1/2 pathway by transferring the exosomal shuttle microRNAs, including miR-490, into hepatocellular carcinoma cells
<sup><xref ref-type="bibr" rid="ref-114">114</xref></sup>.</p>
</sec>
<sec>
<title>Perspectives on mast cells in diseases</title>
<p>Traditionally, MCs have been implicated in allergic diseases. Efficacy of omalizumab—humanized anti-IgE monoclonal antibody (mAb)—and mAbs targeting Th2 cytokines or Th2 cytokine receptors for the treatment of asthma and other allergic diseases supports crucial pathogenic roles for MCs in these diseases
<sup><xref ref-type="bibr" rid="ref-115">115</xref>–
<xref ref-type="bibr" rid="ref-117">117</xref></sup>. Among the mAbs targeting cytokine/receptors, the most illustrative example is dupilumab (mAb for IL4Rα, the subunit shared by IL-4 and IL-13 receptors). This mAb blocks the functions of both IL-4 and IL-13 and is highly efficacious for the treatment of atopic dermatitis
<sup><xref ref-type="bibr" rid="ref-118">118</xref></sup> and asthma
<sup><xref ref-type="bibr" rid="ref-119">119</xref>,
<xref ref-type="bibr" rid="ref-120">120</xref></sup>. However, effects of dupilumab likely reflect pleiotropic functions of IL-4 and IL-13 in immune and non-immune cells.</p>
<p>MCs are considered an important player in inflammation-associated diseases in general, as recent studies have extended their potential role in other diseases. For example, MCs seem to be involved in gastrointestinal diseases such as inflammatory bowel disease, celiac disease, and irritable bowel syndrome
<sup><xref ref-type="bibr" rid="ref-121">121</xref></sup>. The phenotype and the activation status of MCs rather than the absolute numbers in the intestinal mucosa are important for the development and progression of the diseases
<sup><xref ref-type="bibr" rid="ref-122">122</xref></sup>. MCs might also play a role in atherosclerosis. Immunohistochemical studies in autopsied human subjects and studies in murine atherosclerotic models have collectively provided evidence that the compounds released by activated MCs might promote atherogenesis at various stages during the development of atherosclerotic lesions
<sup><xref ref-type="bibr" rid="ref-123">123</xref></sup>. MCs can be pro-tumorigenic and anti-tumorigenic
<sup><xref ref-type="bibr" rid="ref-4">4</xref>,
<xref ref-type="bibr" rid="ref-124">124</xref></sup>. A recent study found that immune cells such as MCs, tumor-associated neutrophils, tumor-infiltrating macrophages, and myeloid-derived suppressor cells promote prostate cancer via various types of intercellular signaling
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup>. With regard to neural diseases, MCs might contribute to modulate the intensity of the associated depressive and anxiogenic component on the neuronal and microglial biological front
<sup><xref ref-type="bibr" rid="ref-126">126</xref></sup>. Preclinical evidence suggests that the intestinal microbiota contributes significantly to behavioral and mood disorders. Microbiotic conditions have been linked to pain, anxiety, stress, and depression in humans
<sup><xref ref-type="bibr" rid="ref-126">126</xref></sup>. Far from being substantiated by other studies, symptoms of autism spectrum disorder might also be caused by the mediators derived from MCs which could activate microglia, causing localized inflammation
<sup><xref ref-type="bibr" rid="ref-127">127</xref></sup>. MCs might play a significant role as a neuroimmune connection between these components. The next decade might see unexpected developments in MC research and their clinical translations.</p>
</sec>
</body>
<back>
<ref-list>
<ref id="ref-1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pejler</surname><given-names>G</given-names></name><name><surname>Abrink</surname><given-names>M</given-names></name><name><surname>Ringvall</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Mast cell proteases.</article-title>
<source/><italic toggle="yes">Adv Immunol.</italic>
<year>2007</year>;<volume>95</volume>:<fpage>167</fpage>–<lpage>255</lpage>.
<pub-id pub-id-type="doi">10.1016/S0065-2776(07)95006-3</pub-id>
<pub-id pub-id-type="pmid">17869614</pub-id></mixed-citation>
</ref>
<ref id="ref-2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dwyer</surname><given-names>DF</given-names></name><name><surname>Barrett</surname><given-names>NA</given-names></name><name><surname>Austen</surname><given-names>KF</given-names></name></person-group>:
<article-title>Expression profiling of constitutive mast cells reveals a unique identity within the immune system.</article-title>
<source/><italic toggle="yes">Nat Immunol.</italic>
<year>2016</year>;<volume>17</volume>(<issue>7</issue>):<fpage>878</fpage>–<lpage>87</lpage>.
<pub-id pub-id-type="doi">10.1038/ni.3445</pub-id>
<!--<pub-id pub-id-type="pmcid">5045264</pub-id>-->
<pub-id pub-id-type="pmid">27135604</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726325855">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klein</surname><given-names>O</given-names></name><name><surname>Sagi-Eisenberg</surname><given-names>R</given-names></name></person-group>:
<article-title>Anaphylactic Degranulation of Mast Cells: Focus on Compound Exocytosis.</article-title>
<source/><italic toggle="yes">J Immunol Res.</italic>
<year>2019</year>;<volume>2019</volume>:<fpage>9542656</fpage>.
<pub-id pub-id-type="doi">10.1155/2019/9542656</pub-id>
<!--<pub-id pub-id-type="pmcid">6442490</pub-id>-->
<pub-id pub-id-type="pmid">31011586</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735610312">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Varricchi</surname><given-names>G</given-names></name><name><surname>Galdiero</surname><given-names>MR</given-names></name><name><surname>Loffredo</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Are Mast Cells MASTers in Cancer?</article-title>
<source/><italic toggle="yes">Front Immunol.</italic>
<year>2017</year>;<volume>8</volume>:<fpage>424</fpage>.
<pub-id pub-id-type="doi">10.3389/fimmu.2017.00424</pub-id>
<!--<pub-id pub-id-type="pmcid">5388770</pub-id>-->
<pub-id pub-id-type="pmid">28446910</pub-id></mixed-citation>
</ref>
<ref id="ref-5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Igawa</surname><given-names>S</given-names></name><name><surname>Di Nardo</surname><given-names>A</given-names></name></person-group>:
<article-title>Skin microbiome and mast cells.</article-title>
<source/><italic toggle="yes">Transl Res.</italic>
<year>2017</year>;<volume>184</volume>:<fpage>68</fpage>–<lpage>76</lpage>.
<pub-id pub-id-type="doi">10.1016/j.trsl.2017.03.003</pub-id>
<!--<pub-id pub-id-type="pmcid">5538027</pub-id>-->
<pub-id pub-id-type="pmid">28390799</pub-id></mixed-citation>
</ref>
<ref id="ref-6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zuani</surname><given-names>M</given-names></name><name><surname>Secco</surname><given-names>C</given-names></name><name><surname>Frossi</surname><given-names>B</given-names></name></person-group>:
<article-title>Mast cells at the crossroads of microbiota and IBD.</article-title>
<source/><italic toggle="yes">Eur J Immunol.</italic>
<year>2018</year>;<volume>48</volume>(<issue>12</issue>):<fpage>1929</fpage>–<lpage>37</lpage>.
<pub-id pub-id-type="doi">10.1002/eji.201847504</pub-id>
<pub-id pub-id-type="pmid">30411335</pub-id></mixed-citation>
</ref>
<ref id="ref-7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Freeland</surname><given-names>DMH</given-names></name><name><surname>Nadeau</surname><given-names>KC</given-names></name></person-group>:
<article-title>Food allergy: immune mechanisms, diagnosis and immunotherapy.</article-title>
<source/><italic toggle="yes">Nat Rev Immunol.</italic>
<year>2016</year>;<volume>16</volume>(<issue>12</issue>):<fpage>751</fpage>–<lpage>65</lpage>.
<pub-id pub-id-type="doi">10.1038/nri.2016.111</pub-id>
<!--<pub-id pub-id-type="pmcid">5123910</pub-id>-->
<pub-id pub-id-type="pmid">27795547</pub-id></mixed-citation>
</ref>
<ref id="ref-8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tordesillas</surname><given-names>L</given-names></name><name><surname>Berin</surname><given-names>MC</given-names></name><name><surname>Sampson</surname><given-names>HA</given-names></name></person-group>:
<article-title>Immunology of Food Allergy.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2017</year>;<volume>47</volume>(<issue>1</issue>):<fpage>32</fpage>–<lpage>50</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2017.07.004</pub-id>
<pub-id pub-id-type="pmid">28723552</pub-id></mixed-citation>
</ref>
<ref id="ref-9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kinet</surname><given-names>JP</given-names></name></person-group>:
<article-title>The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology.</article-title>
<source/><italic toggle="yes">Annu Rev Immunol.</italic>
<year>1999</year>;<volume>17</volume>:<fpage>931</fpage>–<lpage>72</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev.immunol.17.1.931</pub-id>
<pub-id pub-id-type="pmid">10358778</pub-id></mixed-citation>
</ref>
<ref id="ref-10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gould</surname><given-names>HJ</given-names></name><name><surname>Sutton</surname><given-names>BJ</given-names></name><name><surname>Beavil</surname><given-names>AJ</given-names></name><etal></etal></person-group>:
<article-title>The biology of IGE and the basis of allergic disease.</article-title>
<source/><italic toggle="yes">Annu Rev Immunol.</italic>
<year>2003</year>;<volume>21</volume>:<fpage>579</fpage>–<lpage>628</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev.immunol.21.120601.141103</pub-id>
<pub-id pub-id-type="pmid">12500981</pub-id></mixed-citation>
</ref>
<ref id="ref-11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilfillan</surname><given-names>AM</given-names></name><name><surname>Tkaczyk</surname><given-names>C</given-names></name></person-group>:
<article-title>Integrated signalling pathways for mast-cell activation.</article-title>
<source/><italic toggle="yes">Nat Rev Immunol.</italic>
<year>2006</year>;<volume>6</volume>(<issue>3</issue>):<fpage>218</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1038/nri1782</pub-id>
<pub-id pub-id-type="pmid">16470226</pub-id></mixed-citation>
</ref>
<ref id="ref-12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilfillan</surname><given-names>AM</given-names></name><name><surname>Rivera</surname><given-names>J</given-names></name></person-group>:
<article-title>The tyrosine kinase network regulating mast cell activation.</article-title>
<source/><italic toggle="yes">Immunol Rev.</italic>
<year>2009</year>;<volume>228</volume>(<issue>1</issue>):<fpage>149</fpage>–<lpage>69</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1600-065X.2008.00742.x</pub-id>
<!--<pub-id pub-id-type="pmcid">2669301</pub-id>-->
<pub-id pub-id-type="pmid">19290926</pub-id></mixed-citation>
</ref>
<ref id="ref-13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jensen-Jarolim</surname><given-names>E</given-names></name><name><surname>Mechtcheriakova</surname><given-names>D</given-names></name><name><surname>Pali-Scholl</surname><given-names>I</given-names></name></person-group>:
<article-title>Cancer and IgE. Introducing the Concept of AllergoOncology</article-title>. (eds E Jensen-Jarolim &amp; Penichet ML) Springer,<year>2010</year>;<fpage>231</fpage>–<lpage>254</lpage>.
<pub-id pub-id-type="doi">10.1007/978-1-60761-451-7</pub-id>
</mixed-citation>
</ref>
<ref id="ref-14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pali-Schöll</surname><given-names>I</given-names></name><name><surname>Jensen-Jarolim</surname><given-names>E</given-names></name></person-group>:
<article-title>The concept of allergen-associated molecular patterns (AAMP).</article-title>
<source/><italic toggle="yes">Curr Opin Immunol.</italic>
<year>2016</year>;<volume>42</volume>:<fpage>113</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.coi.2016.08.004</pub-id>
<pub-id pub-id-type="pmid">27619413</pub-id></mixed-citation>
</ref>
<ref id="ref-15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Sullivan</surname><given-names>BM</given-names></name><name><surname>Allen</surname><given-names>CD</given-names></name></person-group>:
<article-title>Fluorescent
<italic>in vivo</italic> detection reveals that IgE(+) B cells are restrained by an intrinsic cell fate predisposition.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2012</year>;<volume>36</volume>(<issue>5</issue>)<fpage>857</fpage>–<lpage>72</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2012.02.009</pub-id>
<pub-id pub-id-type="pmid">22406270</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/14257003">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>JS</given-names></name><name><surname>Meyer-Hermann</surname><given-names>M</given-names></name><name><surname>Xiangying</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>The distinctive germinal center phase of IgE+ B lymphocytes limits their contribution to the classical memory response.</article-title>
<source/><italic toggle="yes">J Exp Med.</italic>
<year>2013</year>;<volume>210</volume>(<issue>12</issue>):<fpage>2755</fpage>–<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1084/jem.20131539</pub-id>
<!--<pub-id pub-id-type="pmcid">3832920</pub-id>-->
<pub-id pub-id-type="pmid">24218137</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718173281">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laffleur</surname><given-names>B</given-names></name><name><surname>Duchez</surname><given-names>S</given-names></name><name><surname>Tarte</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Self-Restrained B Cells Arise following Membrane IgE Expression.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2015</year>;<volume>10</volume>(<issue>6</issue>):<fpage>900</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.01.023</pub-id>
<pub-id pub-id-type="pmid">25683713</pub-id></mixed-citation>
</ref>
<ref id="ref-18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>JS</given-names></name><name><surname>Narayanan</surname><given-names>S</given-names></name><name><surname>Subramaniam</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Biology of IgE production: IgE cell differentiation and the memory of IgE responses.</article-title>
<source/><italic toggle="yes">Curr Top Microbiol Immunol.</italic>
<year>2015</year>;<volume>388</volume>:<fpage>1</fpage>–<lpage>19</lpage>.
<pub-id pub-id-type="doi">10.1007/978-3-319-13725-4_1</pub-id>
<pub-id pub-id-type="pmid">25553792</pub-id></mixed-citation>
</ref>
<ref id="ref-19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Dolpady</surname><given-names>J</given-names></name><name><surname>Wabl</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Sequential class switching is required for the generation of high affinity IgE antibodies.</article-title>
<source/><italic toggle="yes">J Exp Med.</italic>
<year>2012</year>;<volume>209</volume>(<issue>2</issue>):<fpage>353</fpage>–<lpage>64</lpage>.
<pub-id pub-id-type="doi">10.1084/jem.20111941</pub-id>
<!--<pub-id pub-id-type="pmcid">3280879</pub-id>-->
<pub-id pub-id-type="pmid">22249450</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/13923979">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haniuda</surname><given-names>K</given-names></name><name><surname>Fukao</surname><given-names>S</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Autonomous membrane IgE signaling prevents IgE-memory formation.</article-title>
<source/><italic toggle="yes">Nat Immunol.</italic>
<year>2016</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1109</fpage>–<lpage>17</lpage>.
<pub-id pub-id-type="doi">10.1038/ni.3508</pub-id>
<pub-id pub-id-type="pmid">27428827</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726542045">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Finkelman</surname><given-names>FD</given-names></name><name><surname>Katona</surname><given-names>IM</given-names></name><name><surname>Urban</surname><given-names>JF</given-names><suffix>Jr</suffix></name><etal></etal></person-group>:
<article-title>IL-4 is required to generate and sustain
<italic>in vivo</italic> IgE responses.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>1988</year>;<volume>141</volume>(<issue>7</issue>):<fpage>2335</fpage>–<lpage>41</lpage>.
<pub-id pub-id-type="pmid">2459206</pub-id></mixed-citation>
</ref>
<ref id="ref-22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crotty</surname><given-names>S</given-names></name></person-group>:
<article-title>T follicular helper cell differentiation, function, and roles in disease.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2014</year>;<volume>41</volume>(<issue>4</issue>):<fpage>529</fpage>–<lpage>42</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2014.10.004</pub-id>
<!--<pub-id pub-id-type="pmcid">4223692</pub-id>-->
<pub-id pub-id-type="pmid">25367570</pub-id></mixed-citation>
</ref>
<ref id="ref-23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Iijima</surname><given-names>K</given-names></name><name><surname>Dent</surname><given-names>AL</given-names></name><etal></etal></person-group>:
<article-title>Follicular helper T cells mediate IgE antibody response to airborne allergens.</article-title>
<source/><italic toggle="yes">J Allergy Clin Immunol.</italic>
<year>2017</year>;<volume>139</volume>(<issue>1</issue>):<fpage>300</fpage>–<lpage>313.e7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2016.04.021</pub-id>
<!--<pub-id pub-id-type="pmcid">5115999</pub-id>-->
<pub-id pub-id-type="pmid">27325434</pub-id></mixed-citation>
</ref>
<ref id="ref-24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gowthaman</surname><given-names>U</given-names></name><name><surname>Chen</surname><given-names>JS</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Identification of a T follicular helper cell subset that drives anaphylactic IgE.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2019</year>;<volume>365</volume>(<issue>6456</issue>): pii: eaaw6433.
<pub-id pub-id-type="doi">10.1126/science.aaw6433</pub-id>
<pub-id pub-id-type="pmid">31371561</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736330218">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hsu</surname><given-names>C</given-names></name><name><surname>MacGlashan</surname><given-names>D</given-names><suffix>Jr</suffix></name></person-group>:
<article-title>IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells.</article-title>
<source/><italic toggle="yes">Immunol Lett.</italic>
<year>1996</year>;<volume>52</volume>(<issue>2–3</issue>):<fpage>129</fpage>–<lpage>34</lpage>.
<pub-id pub-id-type="doi">10.1016/0165-2478(96)02599-0</pub-id>
<pub-id pub-id-type="pmid">8905407</pub-id></mixed-citation>
</ref>
<ref id="ref-26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Lantz</surname><given-names>CS</given-names></name><name><surname>Oettgen</surname><given-names>HC</given-names></name><etal></etal></person-group>:
<article-title>IgE enhances mouse mast cell Fc(epsilon)RI expression
<italic>in vitro</italic> and
<italic>in vivo</italic>: evidence for a novel amplification mechanism in IgE-dependent reactions.</article-title>
<source/><italic toggle="yes">J Exp Med.</italic>
<year>1997</year>;<volume>185</volume>(<issue>4</issue>):<fpage>663</fpage>–<lpage>72</lpage>.
<pub-id pub-id-type="doi">10.1084/jem.185.4.663</pub-id>
<!--<pub-id pub-id-type="pmcid">2196143</pub-id>-->
<pub-id pub-id-type="pmid">9034145</pub-id></mixed-citation>
</ref>
<ref id="ref-27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asai</surname><given-names>K</given-names></name><name><surname>Kitaura</surname><given-names>J</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Regulation of mast cell survival by IgE.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2001</year>;<volume>14</volume>(<issue>6</issue>):<fpage>791</fpage>–<lpage>800</lpage>.
<pub-id pub-id-type="doi">10.1016/s1074-7613(01)00157-1</pub-id>
<pub-id pub-id-type="pmid">11420048</pub-id></mixed-citation>
</ref>
<ref id="ref-28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kalesnikoff</surname><given-names>J</given-names></name><name><surname>Huber</surname><given-names>M</given-names></name><name><surname>Lam</surname><given-names>V</given-names></name><etal></etal></person-group>:
<article-title>Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2001</year>;<volume>14</volume>(<issue>6</issue>):<fpage>801</fpage>–<lpage>11</lpage>.
<pub-id pub-id-type="doi">10.1016/s1074-7613(01)00159-5</pub-id>
<pub-id pub-id-type="pmid">11420049</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1000216">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zellweger</surname><given-names>F</given-names></name><name><surname>Buschor</surname><given-names>P</given-names></name><name><surname>Hobi</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.</article-title>
<source/><italic toggle="yes">Cell Death Dis.</italic>
<year>2018</year>;<volume>9</volume>(<issue>5</issue>):<fpage>510</fpage>.
<pub-id pub-id-type="doi">10.1038/s41419-018-0526-9</pub-id>
<!--<pub-id pub-id-type="pmcid">5938712</pub-id>-->
<pub-id pub-id-type="pmid">29724998</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733175540">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>J</given-names></name><name><surname>Owyang</surname><given-names>A</given-names></name><name><surname>Oldham</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2005</year>;<volume>23</volume>(<issue>5</issue>):<fpage>479</fpage>–<lpage>90</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2005.09.015</pub-id>
<pub-id pub-id-type="pmid">16286016</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1029918">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hammad</surname><given-names>H</given-names></name><name><surname>Chieppa</surname><given-names>M</given-names></name><name><surname>Perros</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells.</article-title>
<source/><italic toggle="yes">Nat Med.</italic>
<year>2009</year>;<volume>15</volume>(<issue>4</issue>):<fpage>410</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1038/nm.1946</pub-id>
<!--<pub-id pub-id-type="pmcid">2789255</pub-id>-->
<pub-id pub-id-type="pmid">19330007</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1159008">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moussion</surname><given-names>C</given-names></name><name><surname>Ortega</surname><given-names>N</given-names></name><name><surname>Girard</surname><given-names>JP</given-names></name></person-group>:
<article-title>The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells
<italic>in vivo</italic>: a novel 'alarmin'?</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2008</year>;<volume>3</volume>(<issue>10</issue>):<fpage>e3331</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0003331</pub-id>
<!--<pub-id pub-id-type="pmcid">2556082</pub-id>-->
<pub-id pub-id-type="pmid">18836528</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/724192038">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wood</surname><given-names>IS</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Trayhurn</surname><given-names>P</given-names></name></person-group>:
<article-title>IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes.</article-title>
<source/><italic toggle="yes">Biochem Biophys Res Commun.</italic>
<year>2009</year>;<volume>384</volume>(<issue>1</issue>):<fpage>105</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.bbrc.2009.04.081</pub-id>
<pub-id pub-id-type="pmid">19393621</pub-id></mixed-citation>
</ref>
<ref id="ref-34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lefrançais</surname><given-names>E</given-names></name><name><surname>Cayrol</surname><given-names>C</given-names></name></person-group>:
<article-title>Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members.</article-title>
<source/><italic toggle="yes">Eur Cytokine Netw.</italic>
<year>2012</year>;<volume>23</volume>(<issue>4</issue>):<fpage>120</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1684/ecn.2012.0320</pub-id>
<pub-id pub-id-type="pmid">23306193</pub-id></mixed-citation>
</ref>
<ref id="ref-35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Ganesh</surname><given-names>G</given-names></name><name><surname>Sippola</surname><given-names>H</given-names></name></person-group>:
<article-title>Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation.</article-title>
<source/><italic toggle="yes">J Biol Chem.</italic>
<year>2014</year>;<volume>289</volume>(<issue>1</issue>):<fpage>237</fpage>–<lpage>50</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.M112.435156</pub-id>
<!--<pub-id pub-id-type="pmcid">3879547</pub-id>-->
<pub-id pub-id-type="pmid">24257755</pub-id></mixed-citation>
</ref>
<ref id="ref-36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pinto</surname><given-names>SM</given-names></name><name><surname>Subbannayya</surname><given-names>Y</given-names></name><name><surname>Rex</surname><given-names>DA</given-names></name><etal></etal></person-group>:
<article-title>A network map of IL-33 signaling pathway.</article-title>
<source/><italic toggle="yes">J Cell Commun Signal.</italic>
<year>2018</year>;<volume>12</volume>(<issue>3</issue>):<fpage>615</fpage>–<lpage>24</lpage>.
<pub-id pub-id-type="doi">10.1007/s12079-018-0464-4</pub-id>
<!--<pub-id pub-id-type="pmcid">6039344</pub-id>-->
<pub-id pub-id-type="pmid">29705949</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733154570">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kakkar</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>RT</given-names></name></person-group>:
<article-title>The IL-33/ST2 pathway: therapeutic target and novel biomarker.</article-title>
<source/><italic toggle="yes">Nat Rev Drug Discov.</italic>
<year>2008</year>;<volume>7</volume>(<issue>10</issue>):<fpage>827</fpage>–<lpage>40</lpage>.
<pub-id pub-id-type="doi">10.1038/nrd2660</pub-id>
<!--<pub-id pub-id-type="pmcid">4277436</pub-id>-->
<pub-id pub-id-type="pmid">18827826</pub-id></mixed-citation>
</ref>
<ref id="ref-38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Komai-Koma</surname><given-names>M</given-names></name><name><surname>Brombacher</surname><given-names>F</given-names></name><name><surname>Pushparaj</surname><given-names>PN</given-names></name><etal></etal></person-group>:
<article-title>Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice.</article-title>
<source/><italic toggle="yes">Allergy.</italic>
<year>2012</year>;<volume>67</volume>(<issue>9</issue>):<fpage>1118</fpage>–<lpage>26</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1398-9995.2012.02859.x</pub-id>
<!--<pub-id pub-id-type="pmcid">3660789</pub-id>-->
<pub-id pub-id-type="pmid">22702477</pub-id></mixed-citation>
</ref>
<ref id="ref-39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allakhverdi</surname><given-names>Z</given-names></name><name><surname>Smith</surname><given-names>DE</given-names></name><name><surname>Comeau</surname><given-names>MR</given-names></name><etal></etal></person-group>:
<article-title>Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2007</year>;<volume>179</volume>(<issue>4</issue>):<fpage>2051</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.179.4.2051</pub-id>
<pub-id pub-id-type="pmid">17675461</pub-id></mixed-citation>
</ref>
<ref id="ref-40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>IL-33 promotes airway remodeling and is a marker of asthma disease severity.</article-title>
<source/><italic toggle="yes">J Asthma.</italic>
<year>2014</year>;<volume>51</volume>(<issue>8</issue>):<fpage>863</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.3109/02770903.2014.921196</pub-id>
<pub-id pub-id-type="pmid">24796648</pub-id></mixed-citation>
</ref>
<ref id="ref-41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reh</surname><given-names>DD</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ramanathan</surname><given-names>M</given-names><suffix>Jr</suffix></name><etal></etal></person-group>:
<article-title>Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33.</article-title>
<source/><italic toggle="yes">Am J Rhinol Allergy.</italic>
<year>2010</year>;<volume>24</volume>(<issue>2</issue>):<fpage>105</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.2500/ajra.2010.24.3446</pub-id>
<!--<pub-id pub-id-type="pmcid">2904061</pub-id>-->
<pub-id pub-id-type="pmid">20338108</pub-id></mixed-citation>
</ref>
<ref id="ref-42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liew</surname><given-names>FY</given-names></name><name><surname>Girard</surname><given-names>JP</given-names></name><name><surname>Turnquist</surname><given-names>HR</given-names></name></person-group>:
<article-title>Interleukin-33 in health and disease.</article-title>
<source/><italic toggle="yes">Nat Rev Immunol.</italic>
<year>2016</year>;<volume>16</volume>(<issue>11</issue>):<fpage>676</fpage>–<lpage>89</lpage>.
<pub-id pub-id-type="doi">10.1038/nri.2016.95</pub-id>
<pub-id pub-id-type="pmid">27640624</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726756209">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saluja</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Church</surname><given-names>MK</given-names></name><etal></etal></person-group>:
<article-title>The role of IL-33 and mast cells in allergy and inflammation.</article-title>
<source/><italic toggle="yes">Clin Transl Allergy.</italic>
<year>2015</year>;<volume>5</volume>:<fpage>33</fpage>.
<pub-id pub-id-type="doi">10.1186/s13601-015-0076-5</pub-id>
<!--<pub-id pub-id-type="pmcid">4588911</pub-id>-->
<pub-id pub-id-type="pmid">26425339</pub-id></mixed-citation>
</ref>
<ref id="ref-44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Makrinioti</surname><given-names>H</given-names></name><name><surname>Toussaint</surname><given-names>M</given-names></name><name><surname>Jackson</surname><given-names>DJ</given-names></name><etal></etal></person-group>:
<article-title>Role of interleukin 33 in respiratory allergy and asthma.</article-title>
<source/><italic toggle="yes">Lancet Respir Med.</italic>
<year>2014</year>;<volume>2</volume>(<issue>3</issue>):<fpage>226</fpage>–<lpage>37</lpage>.
<pub-id pub-id-type="doi">10.1016/S2213-2600(13)70261-3</pub-id>
<pub-id pub-id-type="pmid">24621684</pub-id></mixed-citation>
</ref>
<ref id="ref-45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sjöberg</surname><given-names>LC</given-names></name><name><surname>Gregory</surname><given-names>JA</given-names></name><name><surname>Dahlén</surname><given-names>SE</given-names></name><etal></etal></person-group>:
<article-title>Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells.</article-title>
<source/><italic toggle="yes">Allergy.</italic>
<year>2015</year>;<volume>70</volume>(<issue>5</issue>):<fpage>514</fpage>–<lpage>21</lpage>.
<pub-id pub-id-type="doi">10.1111/all.12590</pub-id>
<pub-id pub-id-type="pmid">25660244</pub-id></mixed-citation>
</ref>
<ref id="ref-46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teufelberger</surname><given-names>AR</given-names></name><name><surname>Nordengrün</surname><given-names>M</given-names></name><name><surname>Braun</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>The IL-33/ST2 axis is crucial in type 2 airway responses induced by
<italic>Staphylococcus aureus</italic>-derived serine protease-like protein D.</article-title>
<source/><italic toggle="yes">J Allergy Clin Immunol.</italic>
<year>2018</year>;<volume>141</volume>(<issue>2</issue>):<fpage>549</fpage>–<lpage>559.e7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2017.05.004</pub-id>
<pub-id pub-id-type="pmid">28532656</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727641794">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Kanaoka</surname><given-names>Y</given-names></name><name><surname>Barrett</surname><given-names>NA</given-names></name><etal></etal></person-group>:
<article-title>Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2015</year>;<volume>195</volume>(<issue>8</issue>):<fpage>3537</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.1500905</pub-id>
<!--<pub-id pub-id-type="pmcid">4592820</pub-id>-->
<pub-id pub-id-type="pmid">26342029</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725770160">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drube</surname><given-names>S</given-names></name><name><surname>Kraft</surname><given-names>F</given-names></name><name><surname>Dudeck</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>MK2/3 Are Pivotal for IL-33-Induced and Mast Cell-Dependent Leukocyte Recruitment and the Resulting Skin Inflammation.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2016</year>;<volume>197</volume>(<issue>9</issue>):<fpage>3662</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.1600658</pub-id>
<pub-id pub-id-type="pmid">27694493</pub-id></mixed-citation>
</ref>
<ref id="ref-49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Noval Rivas</surname><given-names>M</given-names></name><name><surname>Burton</surname><given-names>OT</given-names></name><name><surname>Oettgen</surname><given-names>HC</given-names></name><etal></etal></person-group>:
<article-title>IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function.</article-title>
<source/><italic toggle="yes">J Allergy Clin Immunol.</italic>
<year>2016</year>;<volume>138</volume>(<issue>3</issue>):<fpage>801</fpage>–<lpage>811.e9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2016.02.030</pub-id>
<!--<pub-id pub-id-type="pmcid">5014699</pub-id>-->
<pub-id pub-id-type="pmid">27177780</pub-id></mixed-citation>
</ref>
<ref id="ref-50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leyva-Castillo</surname><given-names>JM</given-names></name><name><surname>Galand</surname><given-names>C</given-names></name><name><surname>Kam</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Mechanical Skin Injury Promotes Food Anaphylaxis by Driving Intestinal Mast Cell Expansion.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2019</year>;<volume>50</volume>(<issue>5</issue>):<fpage>1262</fpage>–<lpage>1275.e4</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.023</pub-id>
<!--<pub-id pub-id-type="pmcid">6531322</pub-id>-->
<pub-id pub-id-type="pmid">31027995</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735595793">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galand</surname><given-names>C</given-names></name><name><surname>Leyva-Castillo</surname><given-names>JM</given-names></name><name><surname>Yoon</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells.</article-title>
<source/><italic toggle="yes">J Allergy Clin Immunol.</italic>
<year>2016</year>;<volume>138</volume>(<issue>5</issue>):<fpage>1356</fpage>–<lpage>66</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2016.03.056</pub-id>
<!--<pub-id pub-id-type="pmcid">5099088</pub-id>-->
<pub-id pub-id-type="pmid">27372570</pub-id></mixed-citation>
</ref>
<ref id="ref-52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimokawa</surname><given-names>C</given-names></name><name><surname>Kanaya</surname><given-names>T</given-names></name><name><surname>Hachisuka</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Mast Cells Are Crucial for Induction of Group 2 Innate Lymphoid Cells and Clearance of Helminth Infections.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2017</year>;<volume>46</volume>(<issue>5</issue>):<fpage>863</fpage>–<lpage>874.e4</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2017.04.017</pub-id>
<pub-id pub-id-type="pmid">28514691</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727620732">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morita</surname><given-names>H</given-names></name><name><surname>Arae</surname><given-names>K</given-names></name><name><surname>Unno</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2015</year>;<volume>43</volume>(<issue>1</issue>):<fpage>175</fpage>–<lpage>86</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.021</pub-id>
<!--<pub-id pub-id-type="pmcid">4533925</pub-id>-->
<pub-id pub-id-type="pmid">26200013</pub-id></mixed-citation>
</ref>
<ref id="ref-54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>T</given-names></name><name><surname>Kasakura</surname><given-names>K</given-names></name></person-group>:
<article-title>Mast Cell Eavesdropping on Bacterial Communications.</article-title>
<source/><italic toggle="yes">Cell Host Microbe.</italic>
<year>2019</year>;<volume>26</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1016/j.chom.2019.06.006</pub-id>
<pub-id pub-id-type="pmid">31295422</pub-id></mixed-citation>
</ref>
<ref id="ref-55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McNeil</surname><given-names>BD</given-names></name><name><surname>Pundir</surname><given-names>P</given-names></name><name><surname>Meeker</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2015</year>;<volume>519</volume>(<issue>7542</issue>):<fpage>237</fpage>–<lpage>41</lpage>.
<pub-id pub-id-type="doi">10.1038/nature14022</pub-id>
<!--<pub-id pub-id-type="pmcid">4359082</pub-id>-->
<pub-id pub-id-type="pmid">25517090</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725281360">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tatemoto</surname><given-names>K</given-names></name><name><surname>Nozaki</surname><given-names>Y</given-names></name><name><surname>Tsuda</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>Endogenous protein and enzyme fragments induce immunoglobulin E-independent activation of mast cells via a G protein-coupled receptor, MRGPRX2.</article-title>
<source/><italic toggle="yes">Scand J Immunol.</italic>
<year>2018</year>;<volume>87</volume>(<issue>5</issue>):<fpage>e12655</fpage>.
<pub-id pub-id-type="doi">10.1111/sji.12655</pub-id>
<pub-id pub-id-type="pmid">29484687</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732784365">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pundir</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Vasavda</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>A Connective Tissue Mast-Cell-Specific Receptor Detects Bacterial Quorum-Sensing Molecules and Mediates Antibacterial Immunity.</article-title>
<source/><italic toggle="yes">Cell Host Microbe.</italic>
<year>2019</year>;<volume>26</volume>(<issue>1</issue>):<fpage>114</fpage>–<lpage>122.e8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.chom.2019.06.003</pub-id>
<!--<pub-id pub-id-type="pmcid">6649664</pub-id>-->
<pub-id pub-id-type="pmid">31278040</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736141954">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gaudenzio</surname><given-names>N</given-names></name><name><surname>Sibilano</surname><given-names>R</given-names></name><name><surname>Marichal</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Different activation signals induce distinct mast cell degranulation strategies.</article-title>
<source/><italic toggle="yes">J Clin Invest.</italic>
<year>2016</year>;<volume>126</volume>(<issue>10</issue>):<fpage>3981</fpage>–<lpage>98</lpage>.
<pub-id pub-id-type="doi">10.1172/JCI85538</pub-id>
<!--<pub-id pub-id-type="pmcid">5096814</pub-id>-->
<pub-id pub-id-type="pmid">27643442</pub-id></mixed-citation>
</ref>
<ref id="ref-59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>H</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><etal></etal></person-group>:
<article-title>Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization.</article-title>
<source/><italic toggle="yes">J Biol Chem.</italic>
<year>2011</year>;<volume>286</volume>(<issue>52</issue>):<fpage>44739</fpage>–<lpage>49</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.M111.277152</pub-id>
<!--<pub-id pub-id-type="pmcid">3247983</pub-id>-->
<pub-id pub-id-type="pmid">22069323</pub-id></mixed-citation>
</ref>
<ref id="ref-60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>LL-37-induced human mast cell activation through G protein-coupled receptor MrgX2.</article-title>
<source/><italic toggle="yes">Int Immunopharmacol.</italic>
<year>2017</year>;<volume>49</volume>:<fpage>6</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1016/j.intimp.2017.05.016</pub-id>
<pub-id pub-id-type="pmid">28549244</pub-id></mixed-citation>
</ref>
<ref id="ref-61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reinholz</surname><given-names>M</given-names></name><name><surname>Ruzicka</surname><given-names>T</given-names></name><name><surname>Schauber</surname><given-names>J</given-names></name></person-group>:
<article-title>Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease.</article-title>
<source/><italic toggle="yes">Ann Dermatol.</italic>
<year>2012</year>;<volume>24</volume>(<issue>2</issue>):<fpage>126</fpage>–<lpage>35</lpage>.
<pub-id pub-id-type="doi">10.5021/ad.2012.24.2.126</pub-id>
<!--<pub-id pub-id-type="pmcid">3346901</pub-id>-->
<pub-id pub-id-type="pmid">22577261</pub-id></mixed-citation>
</ref>
<ref id="ref-62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muto</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Vanderberghe</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea.</article-title>
<source/><italic toggle="yes">J Invest Dermatol.</italic>
<year>2014</year>;<volume>134</volume>(<issue>11</issue>):<fpage>2728</fpage>–<lpage>36</lpage>.
<pub-id pub-id-type="doi">10.1038/jid.2014.222</pub-id>
<!--<pub-id pub-id-type="pmcid">4199909</pub-id>-->
<pub-id pub-id-type="pmid">24844861</pub-id></mixed-citation>
</ref>
<ref id="ref-63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manorak</surname><given-names>W</given-names></name><name><surname>Idahosa</surname><given-names>C</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.</article-title>
<source/><italic toggle="yes">Respir Res.</italic>
<year>2018</year>;<volume>19</volume>(<issue>1</issue>):<fpage>1</fpage>.
<pub-id pub-id-type="doi">10.1186/s12931-017-0698-3</pub-id>
<!--<pub-id pub-id-type="pmcid">5751818</pub-id>-->
<pub-id pub-id-type="pmid">29295703</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732394168">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fujisawa</surname><given-names>D</given-names></name><name><surname>Kashiwakura</surname><given-names>J</given-names></name><name><surname>Kita</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria.</article-title>
<source/><italic toggle="yes">J Allergy Clin Immunol.</italic>
<year>2014</year>;<volume>134</volume>(<issue>3</issue>):<fpage>622</fpage>–<lpage>633.e9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2014.05.004</pub-id>
<pub-id pub-id-type="pmid">24954276</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718463094">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meixiong</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>M</given-names></name><name><surname>Limjunyawong</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch.</article-title>
<source/><italic toggle="yes">Immunity.</italic>
<year>2019</year>;<volume>50</volume>(<issue>5</issue>):<fpage>1163</fpage>–<lpage>1171.e5</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.013</pub-id>
<!--<pub-id pub-id-type="pmcid">6531358</pub-id>-->
<pub-id pub-id-type="pmid">31027996</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735602843">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vocanson</surname><given-names>M</given-names></name><name><surname>Hennino</surname><given-names>A</given-names></name><name><surname>Rozières</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Effector and regulatory mechanisms in allergic contact dermatitis.</article-title>
<source/><italic toggle="yes">Allergy.</italic>
<year>2009</year>;<volume>64</volume>(<issue>12</issue>):<fpage>1699</fpage>–<lpage>714</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1398-9995.2009.02082.x</pub-id>
<pub-id pub-id-type="pmid">19839974</pub-id></mixed-citation>
</ref>
<ref id="ref-67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arizono</surname><given-names>N</given-names></name><name><surname>Matsuda</surname><given-names>S</given-names></name><name><surname>Hattori</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Anatomical variation in mast cell nerve associations in the rat small intestine, heart, lung, and skin. Similarities of distances between neural processes and mast cells, eosinophils, or plasma cells in the jejunal lamina propria.</article-title>
<source/><italic toggle="yes">Lab Invest.</italic>
<year>1990</year>;<volume>62</volume>(<issue>5</issue>):<fpage>626</fpage>–<lpage>34</lpage>.
<pub-id pub-id-type="pmid">2342332</pub-id></mixed-citation>
</ref>
<ref id="ref-68">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bienenstock</surname><given-names>J</given-names></name><name><surname>MacQueen</surname><given-names>G</given-names></name><name><surname>Sestini</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Mast cell/nerve interactions
<italic>in vitro</italic> and
<italic>in vivo</italic>.</article-title>
<source/><italic toggle="yes">Am Rev Respir Dis.</italic>
<year>1991</year>;<volume>143</volume>(<issue>3 Pt 2</issue>):<fpage>S55</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1164/ajrccm/143.3_Pt_2.S55</pub-id>
<pub-id pub-id-type="pmid">2003692</pub-id></mixed-citation>
</ref>
<ref id="ref-69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Purcell</surname><given-names>WM</given-names></name><name><surname>Atterwill</surname><given-names>CK</given-names></name></person-group>:
<article-title>Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives.</article-title>
<source/><italic toggle="yes">Neurochem Res.</italic>
<year>1995</year>;<volume>20</volume>(<issue>5</issue>):<fpage>521</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1007/bf01694534</pub-id>
<pub-id pub-id-type="pmid">7643958</pub-id></mixed-citation>
</ref>
<ref id="ref-70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Yumoto</surname><given-names>K</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name></person-group>:
<article-title>An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases.</article-title>
<source/><italic toggle="yes">Allergol Int.</italic>
<year>2007</year>;<volume>56</volume>(<issue>4</issue>):<fpage>403</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.2332/allergolint.O-07-486</pub-id>
<pub-id pub-id-type="pmid">17713360</pub-id></mixed-citation>
</ref>
<ref id="ref-71">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Serhan</surname><given-names>N</given-names></name><name><surname>Basso</surname><given-names>L</given-names></name><name><surname>Sibilano</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation.</article-title>
<source/><italic toggle="yes">Nat Immunol.</italic>
<year>2019</year>;<volume>20</volume>(<issue>11</issue>):<fpage>1435</fpage>–<lpage>43</lpage>.
<pub-id pub-id-type="doi">10.1038/s41590-019-0493-z</pub-id>
<!--<pub-id pub-id-type="pmcid">6858877</pub-id>-->
<pub-id pub-id-type="pmid">31591569</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736721262">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-72">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Solinski</surname><given-names>HJ</given-names></name><name><surname>Kriegbaum</surname><given-names>MC</given-names></name><name><surname>Tseng</surname><given-names>PY</given-names></name><etal></etal></person-group>:
<article-title>Nppb Neurons Are Sensors of Mast Cell-Induced Itch.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2019</year>;<volume>26</volume>(<issue>13</issue>):<fpage>3561</fpage>–<lpage>3573.e4</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2019.02.089</pub-id>
<!--<pub-id pub-id-type="pmcid">6490177</pub-id>-->
<pub-id pub-id-type="pmid">30917312</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735392239">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-73">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Green</surname><given-names>DP</given-names></name><name><surname>Limjunyawong</surname><given-names>N</given-names></name><name><surname>Gour</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>A Mast-Cell-Specific Receptor Mediates Neurogenic Inflammation and Pain.</article-title>
<source/><italic toggle="yes">Neuron.</italic>
<year>2019</year>;<volume>101</volume>(<issue>13</issue>):<fpage>412</fpage>–<lpage>420.e3</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2019.01.012</pub-id>
<!--<pub-id pub-id-type="pmcid">6462816</pub-id>-->
<pub-id pub-id-type="pmid">30686732</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734936929">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-74">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Ganguly</surname><given-names>A</given-names></name><name><surname>Haque</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B
<sub>2</sub> Receptor Antagonist Icatibant Are G Protein Biased Agonists for MRGPRX2 in Mast Cells.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2019</year>;<volume>202</volume>(<issue>4</issue>):<fpage>1229</fpage>–<lpage>38</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.1801227</pub-id>
<!--<pub-id pub-id-type="pmcid">6369923</pub-id>-->
<pub-id pub-id-type="pmid">30651343</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734876990">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-75">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Babina</surname><given-names>M</given-names></name><name><surname>Guhl</surname><given-names>S</given-names></name><name><surname>Artuc</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Allergic FcεRI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF.</article-title>
<source/><italic toggle="yes">Allergy.</italic>
<year>2018</year>;<volume>73</volume>(<issue>1</issue>):<fpage>256</fpage>–<lpage>60</lpage>.
<pub-id pub-id-type="doi">10.1111/all.13301</pub-id>
<pub-id pub-id-type="pmid">28859248</pub-id></mixed-citation>
</ref>
<ref id="ref-76">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Babina</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Artuc</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in culture.</article-title>
<source/><italic toggle="yes">Exp Dermatol.</italic>
<year>2018</year>;<volume>27</volume>(<issue>11</issue>):<fpage>1298</fpage>–<lpage>303</lpage>.
<pub-id pub-id-type="doi">10.1111/exd.13762</pub-id>
<pub-id pub-id-type="pmid">30091263</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733793504">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-77">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cop</surname><given-names>N</given-names></name><name><surname>Ebo</surname><given-names>DG</given-names></name><name><surname>Bridts</surname><given-names>CH</given-names></name><etal></etal></person-group>:
<article-title>Influence of IL-6, IL-33, and TNF-α on human mast cell activation: Lessons from single cell analysis by flow cytometry.</article-title>
<source/><italic toggle="yes">Cytometry B Clin Cytom.</italic>
<year>2018</year>;<volume>94</volume>(<issue>3</issue>):<fpage>405</fpage>–<lpage>11</lpage>.
<pub-id pub-id-type="doi">10.1002/cyto.b.21547</pub-id>
<pub-id pub-id-type="pmid">28802100</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/737462000">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-78">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Babina</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Franke</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Yin-Yang of IL-33 in Human Skin Mast Cells: Reduced Degranulation, but Augmented Histamine Synthesis through p38 Activation.</article-title>
<source/><italic toggle="yes">J Invest Dermatol.</italic>
<year>2019</year>;<volume>139</volume>(<issue>7</issue>):<fpage>1516</fpage>–<lpage>1525.e3</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jid.2019.01.013</pub-id>
<pub-id pub-id-type="pmid">30684550</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734925411">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-79">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Guhl</surname><given-names>S</given-names></name><name><surname>Franke</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.</article-title>
<source/><italic toggle="yes">Cells.</italic>
<year>2019</year>;<volume>8</volume>(<issue>4</issue>): pii: E341.
<pub-id pub-id-type="doi">10.3390/cells8040341</pub-id>
<!--<pub-id pub-id-type="pmcid">6523246</pub-id>-->
<pub-id pub-id-type="pmid">30979016</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735576124">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-80">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Widiapradja</surname><given-names>A</given-names></name><name><surname>Manteufel</surname><given-names>EJ</given-names></name><name><surname>Dehlin</surname><given-names>HM</given-names></name><etal></etal></person-group>:
<article-title>Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic Heart.</article-title>
<source/><italic toggle="yes">Sci Rep.</italic>
<year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>11004</fpage>.
<pub-id pub-id-type="doi">10.1038/s41598-019-47369-0</pub-id>
<!--<pub-id pub-id-type="pmcid">6662794</pub-id>-->
<pub-id pub-id-type="pmid">31358823</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736292418">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-81">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartel</surname><given-names>DP</given-names></name></person-group>:
<article-title>MicroRNAs: target recognition and regulatory functions.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2009</year>;<volume>136</volume>(<issue>2</issue>):<fpage>215</fpage>–<lpage>33</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2009.01.002</pub-id>
<!--<pub-id pub-id-type="pmcid">3794896</pub-id>-->
<pub-id pub-id-type="pmid">19167326</pub-id></mixed-citation>
</ref>
<ref id="ref-82">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiang</surname><given-names>HR</given-names></name><name><surname>Schoenfeld</surname><given-names>LW</given-names></name><name><surname>Ruby</surname><given-names>JG</given-names></name><etal></etal></person-group>:
<article-title>Mammalian microRNAs: experimental evaluation of novel and previously annotated genes.</article-title>
<source/><italic toggle="yes">Genes Dev.</italic>
<year>2010</year>;<volume>24</volume>(<issue>10</issue>):<fpage>992</fpage>–<lpage>1009</lpage>.
<pub-id pub-id-type="doi">10.1101/gad.1884710</pub-id>
<!--<pub-id pub-id-type="pmcid">2867214</pub-id>-->
<pub-id pub-id-type="pmid">20413612</pub-id></mixed-citation>
</ref>
<ref id="ref-83">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shefler</surname><given-names>I</given-names></name><name><surname>Salamon</surname><given-names>P</given-names></name><name><surname>Mekori</surname><given-names>YA</given-names></name></person-group>:
<article-title>MicroRNA Involvement in Allergic and Non-Allergic Mast Cell Activation.</article-title>
<source/><italic toggle="yes">Int J Mol Sci.</italic>
<year>2019</year>;<volume>20</volume>(<issue>9</issue>):<fpage>2145</fpage>.
<pub-id pub-id-type="doi">10.3390/ijms20092145</pub-id>
<!--<pub-id pub-id-type="pmcid">6539777</pub-id>-->
<pub-id pub-id-type="pmid">31052286</pub-id></mixed-citation>
</ref>
<ref id="ref-84">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Kosaka</surname><given-names>K</given-names></name><name><surname>Miyazawa</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>miR-142-3p enhances FcεRI-mediated degranulation in mast cells.</article-title>
<source/><italic toggle="yes">Biochem Biophys Res Commun.</italic>
<year>2014</year>;<volume>443</volume>(<issue>3</issue>):<fpage>980</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1016/j.bbrc.2013.12.078</pub-id>
<pub-id pub-id-type="pmid">24361879</pub-id></mixed-citation>
</ref>
<ref id="ref-85">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monticelli</surname><given-names>S</given-names></name><name><surname>Ansel</surname><given-names>KM</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA profiling of the murine hematopoietic system.</article-title>
<source/><italic toggle="yes">Genome Biol.</italic>
<year>2005</year>;<volume>6</volume>(<issue>8</issue>):<fpage>R71</fpage>.
<pub-id pub-id-type="doi">10.1186/gb-2005-6-8-r71</pub-id>
<!--<pub-id pub-id-type="pmcid">1273638</pub-id>-->
<pub-id pub-id-type="pmid">16086853</pub-id></mixed-citation>
</ref>
<ref id="ref-86">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Altered MicroRNA Expression Profiles in Activated Mast Cells Following IgE-FcεRI Cross-Linking with Antigen.</article-title>
<source/><italic toggle="yes">Cell Physiol Biochem.</italic>
<year>2015</year>;<volume>35</volume>(<issue>6</issue>):<fpage>2098</fpage>–<lpage>110</lpage>.
<pub-id pub-id-type="doi">10.1159/000374016</pub-id>
<pub-id pub-id-type="pmid">25895812</pub-id></mixed-citation>
</ref>
<ref id="ref-87">
<label>87</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Biethahn</surname><given-names>K</given-names></name><name><surname>Orinska</surname><given-names>Z</given-names></name><name><surname>Vigorito</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>miRNA-155 controls mast cell activation by regulating the PI3Kγ pathway and anaphylaxis in a mouse model.</article-title>
<source/><italic toggle="yes">Allergy.</italic>
<year>2014</year>;<volume>69</volume>(<issue>6</issue>):<fpage>752</fpage>–<lpage>62</lpage>.
<pub-id pub-id-type="doi">10.1111/all.12407</pub-id>
<pub-id pub-id-type="pmid">24734904</pub-id></mixed-citation>
</ref>
<ref id="ref-88">
<label>88</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abebayehu</surname><given-names>D</given-names></name><name><surname>Spence</surname><given-names>AJ</given-names></name><name><surname>Qayum</surname><given-names>AA</given-names></name><etal></etal></person-group>:
<article-title>Lactic Acid Suppresses IL-33-Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1α-Dependent miR-155 Suppression.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2016</year>;<volume>197</volume>(<issue>7</issue>):<fpage>2909</fpage>–<lpage>17</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.1600651</pub-id>
<!--<pub-id pub-id-type="pmcid">5026940</pub-id>-->
<pub-id pub-id-type="pmid">27559047</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726673130">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-89">
<label>89</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yi</surname><given-names>T</given-names></name><name><surname>Long</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Involvement of the Negative Feedback of IL-33 Signaling in the Anti-Inflammatory Effect of Electro-acupuncture on Allergic Contact Dermatitis via Targeting MicroRNA-155 in Mast Cells.</article-title>
<source/><italic toggle="yes">Inflammation.</italic>
<year>2018</year>;<volume>41</volume>(<issue>3</issue>):<fpage>859</fpage>–<lpage>69</lpage>.
<pub-id pub-id-type="doi">10.1007/s10753-018-0740-8</pub-id>
<pub-id pub-id-type="pmid">29404871</pub-id></mixed-citation>
</ref>
<ref id="ref-90">
<label>90</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qayum</surname><given-names>AA</given-names></name><name><surname>Paranjape</surname><given-names>A</given-names></name><name><surname>Abebayehu</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>IL-10-Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell Function.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2016</year>;<volume>196</volume>(<issue>11</issue>):<fpage>4457</fpage>–<lpage>67</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.1502240</pub-id>
<!--<pub-id pub-id-type="pmcid">4875869</pub-id>-->
<pub-id pub-id-type="pmid">27183599</pub-id></mixed-citation>
</ref>
<ref id="ref-91">
<label>91</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Characterization of microRNA profile in IgE-mediated mouse BMMCs degranulation.</article-title>
<source/><italic toggle="yes">J Microbiol Immunol Infect.</italic>
<year>2018</year>; pii: S1684-1182(18)30477-8.
<pub-id pub-id-type="doi">10.1016/j.jmii.2018.10.006</pub-id>
<pub-id pub-id-type="pmid">30473142</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735382738">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-92">
<label>92</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA-126 accelerates IgE-mediated mast cell degranulation associated with the PI3K/Akt signaling pathway by promoting Ca
<sup>2+</sup> influx.</article-title>
<source/><italic toggle="yes">Exp Ther Med.</italic>
<year>2018</year>;<volume>16</volume>(<issue>3</issue>):<fpage>2763</fpage>–<lpage>2769</lpage>.
<pub-id pub-id-type="doi">10.3892/etm.2018.6510</pub-id>
<!--<pub-id pub-id-type="pmcid">6122504</pub-id>-->
<pub-id pub-id-type="pmid">30186504</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733957477">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-93">
<label>93</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA-223 affects IL-6 secretion in mast cells via the IGF1R/PI3K signaling pathway.</article-title>
<source/><italic toggle="yes">Int J Mol Med.</italic>
<year>2016</year>;<volume>38</volume>(<issue>2</issue>):<fpage>507</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.3892/ijmm.2016.2649</pub-id>
<pub-id pub-id-type="pmid">27354148</pub-id></mixed-citation>
</ref>
<ref id="ref-94">
<label>94</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Just</surname><given-names>J</given-names></name><name><surname>Munk Ipsen</surname><given-names>P</given-names></name><name><surname> Kruhøffer</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Human Mast Cell Sensitization with IgE Increases miRNA-210 Expression.</article-title>
<source/><italic toggle="yes">Int Arch Allergy Immunol.</italic>
<year>2019</year>;<volume>179</volume>(<issue>2</issue>):<fpage>102</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1159/000496513</pub-id>
<pub-id pub-id-type="pmid">30965334</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/737462023">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-95">
<label>95</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA-21-Mediated Inhibition of Mast Cell Degranulation Involved in the Protective Effect of Berberine on 2,4-Dinitrofluorobenzene-Induced Allergic Contact Dermatitis in Rats via p38 Pathway.</article-title>
<source/><italic toggle="yes">Inflammation.</italic>
<year>2018</year>;<volume>41</volume>(<issue>2</issue>):<fpage>689</fpage>–<lpage>99</lpage>.
<pub-id pub-id-type="doi">10.1007/s10753-017-0723-1</pub-id>
<pub-id pub-id-type="pmid">29282578</pub-id></mixed-citation>
</ref>
<ref id="ref-96">
<label>96</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mayoral</surname><given-names>RJ</given-names></name><name><surname>Deho</surname><given-names>L</given-names></name><name><surname>Rusca</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>MiR-221 influences effector functions and actin cytoskeleton in mast cells.</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2011</year>;<volume>6</volume>(<issue>10</issue>):<fpage>e26133</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0026133</pub-id>
<!--<pub-id pub-id-type="pmcid">3192147</pub-id>-->
<pub-id pub-id-type="pmid">22022537</pub-id></mixed-citation>
</ref>
<ref id="ref-97">
<label>97</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mayoral</surname><given-names>RJ</given-names></name><name><surname>Pipkin</surname><given-names>ME</given-names></name><name><surname>Pachkov</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA-221-222 regulate the cell cycle in mast cells.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2008</year>;<volume>182</volume>(<issue>1</issue>):<fpage>433</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.182.1.433</pub-id>
<!--<pub-id pub-id-type="pmcid">2610349</pub-id>-->
<pub-id pub-id-type="pmid">19109175</pub-id></mixed-citation>
</ref>
<ref id="ref-98">
<label>98</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>miRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog/p38/Nuclear Factor-kappaB Pathway.</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2016</year>;<volume>11</volume>(<issue>2</issue>):<fpage>e0148821</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0148821</pub-id>
<!--<pub-id pub-id-type="pmcid">4764704</pub-id>-->
<pub-id pub-id-type="pmid">26901347</pub-id></mixed-citation>
</ref>
<ref id="ref-99">
<label>99</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>Q</given-names></name><etal></etal></person-group>:
<article-title>MiR-302e attenuates allergic inflammation
<italic>in vitro</italic> model by targeting RelA.</article-title>
<source/><italic toggle="yes">Biosci Rep.</italic>
<year>2018</year>;<volume>38</volume>(<issue>3</issue>): pii: BSR20180025.
<pub-id pub-id-type="doi">10.1042/BSR20180025</pub-id>
<!--<pub-id pub-id-type="pmcid">6435536</pub-id>-->
<pub-id pub-id-type="pmid">29748238</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733250833">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-100">
<label>100</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rusca</surname><given-names>N</given-names></name><name><surname>Dehò</surname><given-names>L</given-names></name><name><surname>Montagner</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>MiR-146a and NF-κB1 regulate mast cell survival and T lymphocyte differentiation.</article-title>
<source/><italic toggle="yes">Mol Cell Biol.</italic>
<year>2012</year>;<volume>32</volume>(<issue>21</issue>):<fpage>4432</fpage>–<lpage>44</lpage>.
<pub-id pub-id-type="doi">10.1128/MCB.00824-12</pub-id>
<!--<pub-id pub-id-type="pmcid">3486148</pub-id>-->
<pub-id pub-id-type="pmid">22927641</pub-id></mixed-citation>
</ref>
<ref id="ref-101">
<label>101</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taganov</surname><given-names>KD</given-names></name><name><surname>Boldin</surname><given-names>MP</given-names></name><name><surname>Chang</surname><given-names>KJ</given-names></name><etal></etal></person-group>:
<article-title>NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2006</year>;<volume>103</volume>(<issue>33</issue>):<fpage>12481</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.0605298103</pub-id>
<!--<pub-id pub-id-type="pmcid">1567904</pub-id>-->
<pub-id pub-id-type="pmid">16885212</pub-id></mixed-citation>
</ref>
<ref id="ref-102">
<label>102</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Boldin</surname><given-names>MP</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>miR-146a controls the resolution of T cell responses in mice.</article-title>
<source/><italic toggle="yes">J Exp Med.</italic>
<year>2012</year>;<volume>209</volume>(<issue>9</issue>):<fpage>1655</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1084/jem.20112218</pub-id>
<!--<pub-id pub-id-type="pmcid">3428948</pub-id>-->
<pub-id pub-id-type="pmid">22891274</pub-id></mixed-citation>
</ref>
<ref id="ref-103">
<label>103</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA-143 downregulates interleukin-13 receptor alpha1 in human mast cells.</article-title>
<source/><italic toggle="yes">Int J Mol Sci.</italic>
<year>2013</year>;<volume>14</volume>(<issue>8</issue>):<fpage>16958</fpage>–<lpage>69</lpage>.
<pub-id pub-id-type="doi">10.3390/ijms140816958</pub-id>
<!--<pub-id pub-id-type="pmcid">3759945</pub-id>-->
<pub-id pub-id-type="pmid">23965966</pub-id></mixed-citation>
</ref>
<ref id="ref-104">
<label>104</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>hsa-miR-20a-5p attenuates allergic inflammation in HMC-1 cells by targeting HDAC4.</article-title>
<source/><italic toggle="yes">Mol Immunol.</italic>
<year>2019</year>;<volume>107</volume>:<fpage>84</fpage>–<lpage>90</lpage>.
<pub-id pub-id-type="doi">10.1016/j.molimm.2019.01.010</pub-id>
<pub-id pub-id-type="pmid">30684894</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734926725">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-105">
<label>105</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shefler</surname><given-names>I</given-names></name><name><surname>Pasmanik-Chor</surname><given-names>M</given-names></name><name><surname>Kidron</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>T cell-derived microvesicles induce mast cell production of IL-24: relevance to inflammatory skin diseases.</article-title>
<source/><italic toggle="yes">J Allergy Clin Immunol.</italic>
<year>2014</year>;<volume>133</volume>(<issue>1</issue>):<fpage>217</fpage>–<lpage>224.e3–3</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2013.04.035</pub-id>
<pub-id pub-id-type="pmid">23768573</pub-id></mixed-citation>
</ref>
<ref id="ref-106">
<label>106</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shefler</surname><given-names>I</given-names></name><name><surname>Salamon</surname><given-names>P</given-names></name><name><surname>Reshef</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>T cell-induced mast cell activation: a role for microparticles released from activated T cells.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2010</year>;<volume>185</volume>(<issue>7</issue>):<fpage>4206</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.1000409</pub-id>
<pub-id pub-id-type="pmid">20810987</pub-id></mixed-citation>
</ref>
<ref id="ref-107">
<label>107</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baram</surname><given-names>D</given-names></name><name><surname>Vaday</surname><given-names>GG</given-names></name><name><surname>Salamon</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2001</year>;<volume>167</volume>(<issue>7</issue>):<fpage>4008</fpage>–<lpage>16</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.167.7.4008</pub-id>
<pub-id pub-id-type="pmid">11564820</pub-id></mixed-citation>
</ref>
<ref id="ref-108">
<label>108</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mor</surname><given-names>A</given-names></name><name><surname>Shefler</surname><given-names>I</given-names></name><name><surname>Salamon</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Characterization of ERK activation in human mast cells stimulated by contact with T cells.</article-title>
<source/><italic toggle="yes">Inflammation.</italic>
<year>2010</year>;<volume>33</volume>(<issue>2</issue>):<fpage>119</fpage>–<lpage>25</lpage>.
<pub-id pub-id-type="doi">10.1007/s10753-009-9165-8</pub-id>
<pub-id pub-id-type="pmid">19908133</pub-id></mixed-citation>
</ref>
<ref id="ref-109">
<label>109</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salamon</surname><given-names>P</given-names></name><name><surname>Shoham</surname><given-names>NG</given-names></name><name><surname>Puxeddu</surname><given-names>I</given-names></name><etal></etal></person-group>:
<article-title>Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance.</article-title>
<source/><italic toggle="yes">J Allergy Clin Immunol.</italic>
<year>2008</year>;<volume>121</volume>(<issue>2</issue>):<fpage>448</fpage>–<lpage>455.e5</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2007.08.054</pub-id>
<pub-id pub-id-type="pmid">18028996</pub-id></mixed-citation>
</ref>
<ref id="ref-110">
<label>110</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shefler</surname><given-names>I</given-names></name><name><surname>Mekori</surname><given-names>YA</given-names></name><name><surname>Mor</surname><given-names>A</given-names></name></person-group>:
<article-title>Stimulation of human mast cells by activated T cells leads to N-Ras activation through Ras guanine nucleotide releasing protein 1.</article-title>
<source/><italic toggle="yes">J Allergy Clin Immunol.</italic>
<year>2008</year>;<volume>122</volume>(<issue>6</issue>):<fpage>1222</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2008.07.024</pub-id>
<pub-id pub-id-type="pmid">18760455</pub-id></mixed-citation>
</ref>
<ref id="ref-111">
<label>111</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shefler</surname><given-names>I</given-names></name><name><surname>Salamon</surname><given-names>P</given-names></name><name><surname>Levi-Schaffer</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA-4443 regulates mast cell activation by T cell-derived microvesicles.</article-title>
<source/><italic toggle="yes">J Allergy Clin Immunol.</italic>
<year>2018</year>;<volume>141</volume>(<issue>6</issue>):<fpage>2132</fpage>–<lpage>2141.e4</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2017.06.045</pub-id>
<pub-id pub-id-type="pmid">28823811</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733424451">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-112">
<label>112</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fenger</surname><given-names>JM</given-names></name><name><surname>Bear</surname><given-names>MD</given-names></name><name><surname>Volinia</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis.</article-title>
<source/><italic toggle="yes">BMC Cancer.</italic>
<year>2014</year>;<volume>14</volume>:<fpage>84</fpage>.
<pub-id pub-id-type="doi">10.1186/1471-2407-14-84</pub-id>
<!--<pub-id pub-id-type="pmcid">3933481</pub-id>-->
<pub-id pub-id-type="pmid">24517413</pub-id></mixed-citation>
</ref>
<ref id="ref-113">
<label>113</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Noh</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>miR-122-SOCS1-JAK2 axis regulates allergic inflammation and allergic inflammation-promoted cellular interactions.</article-title>
<source/><italic toggle="yes">Oncotarget.</italic>
<year>2017</year>;<volume>8</volume>(<issue>38</issue>):<fpage>63155</fpage>–<lpage>63176</lpage>.
<pub-id pub-id-type="doi">10.18632/oncotarget.19149</pub-id>
<!--<pub-id pub-id-type="pmcid">5609911</pub-id>-->
<pub-id pub-id-type="pmid">28968979</pub-id></mixed-citation>
</ref>
<ref id="ref-114">
<label>114</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiong</surname><given-names>L</given-names></name><name><surname>Zhen</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><etal></etal></person-group>:
<article-title>HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs.</article-title>
<source/><italic toggle="yes">Oncol Lett.</italic>
<year>2017</year>;<volume>14</volume>(<issue>2</issue>):<fpage>2141</fpage>–<lpage>2146</lpage>.
<pub-id pub-id-type="doi">10.3892/ol.2017.6433</pub-id>
<!--<pub-id pub-id-type="pmcid">5530191</pub-id>-->
<pub-id pub-id-type="pmid">28781655</pub-id></mixed-citation>
</ref>
<ref id="ref-115">
<label>115</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>T</given-names></name><name><surname>Blank</surname><given-names>U</given-names></name></person-group>:
<article-title>From IgE to Omalizumab.</article-title>
<source/><italic toggle="yes">J Immunol.</italic>
<year>2016</year>;<volume>197</volume>(<issue>11</issue>):<fpage>4187</fpage>–<lpage>4192</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.1601476</pub-id>
<!--<pub-id pub-id-type="pmcid">5123831</pub-id>-->
<pub-id pub-id-type="pmid">27864548</pub-id></mixed-citation>
</ref>
<ref id="ref-116">
<label>116</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holgate</surname><given-names>ST</given-names></name><name><surname>Chuchalin</surname><given-names>AG</given-names></name><name><surname>Hébert</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.</article-title>
<source/><italic toggle="yes">Clin Exp Allergy.</italic>
<year>2004</year>;<volume>34</volume>(<issue>4</issue>):<fpage>632</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1365-2222.2004.1916.x</pub-id>
<pub-id pub-id-type="pmid">15080818</pub-id></mixed-citation>
</ref>
<ref id="ref-117">
<label>117</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maurer</surname><given-names>M</given-names></name><name><surname>Rosén</surname><given-names>K</given-names></name><name><surname>Hsieh</surname><given-names>HJ</given-names></name><etal></etal></person-group>:
<article-title>Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.</article-title>
<source/><italic toggle="yes">N Engl J Med.</italic>
<year>2013</year>;<volume>368</volume>(<issue>10</issue>):<fpage>924</fpage>–<lpage>35</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMoa1215372</pub-id>
<pub-id pub-id-type="pmid">23432142</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717980714">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-118">
<label>118</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simpson</surname><given-names>EL</given-names></name><name><surname>Bieber</surname><given-names>T</given-names></name><name><surname>Guttman-Yassky</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.</article-title>
<source/><italic toggle="yes">N Engl J Med.</italic>
<year>2016</year>;<volume>375</volume>(<issue>24</issue>):<fpage>2335</fpage>–<lpage>48</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMoa1610020</pub-id>
<pub-id pub-id-type="pmid">27690741</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726815273">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-119">
<label>119</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Castro</surname><given-names>M</given-names></name><name><surname>Corren</surname><given-names>J</given-names></name><name><surname>Pavord</surname><given-names>ID</given-names></name><etal></etal></person-group>:
<article-title>Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.</article-title>
<source/><italic toggle="yes">N Engl J Med.</italic>
<year>2018</year>;<volume>378</volume>(<issue>26</issue>):<fpage>2486</fpage>–<lpage>96</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMoa1804092</pub-id>
<pub-id pub-id-type="pmid">29782217</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733272126">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-120">
<label>120</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rabe</surname><given-names>KF</given-names></name><name><surname>Nair</surname><given-names>P</given-names></name><name><surname>Brusselle</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.</article-title>
<source/><italic toggle="yes">N Engl J Med.</italic>
<year>2018</year>;<volume>378</volume>(<issue>26</issue>):<fpage>2475</fpage>–<lpage>85</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMoa1804093</pub-id>
<pub-id pub-id-type="pmid">29782224</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733267646">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-121">
<label>121</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frossi</surname><given-names>B</given-names></name><name><surname>De Carli</surname><given-names>M</given-names></name><name><surname>Calabrò</surname><given-names>A</given-names></name></person-group>:
<article-title>Coeliac Disease and Mast Cells.</article-title>
<source/><italic toggle="yes">Int J Mol Sci.</italic>
<year>2019</year>;<volume>20</volume>(<issue>14</issue>): pii: E3400.
<pub-id pub-id-type="doi">10.3390/ijms20143400</pub-id>
<!--<pub-id pub-id-type="pmcid">6678566</pub-id>-->
<pub-id pub-id-type="pmid">31373285</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736760232">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-122">
<label>122</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Theoharides</surname><given-names>TC</given-names></name><name><surname>Valent</surname><given-names>P</given-names></name><name><surname>Akin</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Mast Cells, Mastocytosis, and Related Disorders.</article-title>
<source/><italic toggle="yes">N Engl J Med.</italic>
<year>2015</year>;<volume>373</volume>(<issue>19</issue>):<fpage>1885</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMc1510021</pub-id>
<pub-id pub-id-type="pmid">26535528</pub-id></mixed-citation>
</ref>
<ref id="ref-123">
<label>123</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kovanen</surname><given-names>PT</given-names></name></person-group>:
<article-title>Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions.</article-title>
<source/><italic toggle="yes">Int J Mol Sci.</italic>
<year>2019</year>;<volume>20</volume>(<issue>18</issue>): pii: E4479.
<pub-id pub-id-type="doi">10.3390/ijms20184479</pub-id>
<!--<pub-id pub-id-type="pmcid">6770933</pub-id>-->
<pub-id pub-id-type="pmid">31514285</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736602353">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-124">
<label>124</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Derakhshani</surname><given-names>A</given-names></name><name><surname>Vahidian</surname><given-names>F</given-names></name><name><surname>Alihasanzadeh</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Mast cells: A double-edged sword in cancer.</article-title>
<source/><italic toggle="yes">Immunol Lett.</italic>
<year>2019</year>;<volume>209</volume>:<fpage>28</fpage>–<lpage>35</lpage>.
<pub-id pub-id-type="doi">10.1016/j.imlet.2019.03.011</pub-id>
<pub-id pub-id-type="pmid">30905824</pub-id></mixed-citation>
</ref>
<ref id="ref-125">
<label>125</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>K</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer.</article-title>
<source/><italic toggle="yes">Cancers (Basel).</italic>
<year>2019</year>;<volume>11</volume>(<issue>8</issue>): pii: E1153.
<pub-id pub-id-type="doi">10.3390/cancers11081153</pub-id>
<!--<pub-id pub-id-type="pmcid">6721573</pub-id>-->
<pub-id pub-id-type="pmid">31408948</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736406366">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-126">
<label>126</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Traina</surname><given-names>G</given-names></name></person-group>:
<article-title>Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases.</article-title>
<source/><italic toggle="yes">Front Cell Neurosci.</italic>
<year>2019</year>;<volume>13</volume>:<fpage>345</fpage>.
<pub-id pub-id-type="doi">10.3389/fncel.2019.00345</pub-id>
<!--<pub-id pub-id-type="pmcid">6682652</pub-id>-->
<pub-id pub-id-type="pmid">31417365</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/736437714">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-127">
<label>127</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Theoharides</surname><given-names>TC</given-names></name><name><surname>Tsilioni</surname><given-names>I</given-names></name><name><surname>Patel</surname><given-names>AB</given-names></name><etal></etal></person-group>:
<article-title>Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders.</article-title>
<source/><italic toggle="yes">Transl Psychiatry.</italic>
<year>2016</year>;<volume>6</volume>(<issue>6</issue>):<fpage>e844</fpage>.
<pub-id pub-id-type="doi">10.1038/tp.2016.77</pub-id>
<!--<pub-id pub-id-type="pmcid">4931610</pub-id>-->
<pub-id pub-id-type="pmid">27351598</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>